<SEC-DOCUMENT>0001564590-22-025112.txt : 20220701
<SEC-HEADER>0001564590-22-025112.hdr.sgml : 20220701
<ACCEPTANCE-DATETIME>20220701170404
ACCESSION NUMBER:		0001564590-22-025112
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220725
FILED AS OF DATE:		20220701
DATE AS OF CHANGE:		20220701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			East Resources Acquisition Co
		CENTRAL INDEX KEY:			0001814287
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				851210472
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39403
		FILM NUMBER:		221062218

	BUSINESS ADDRESS:	
		STREET 1:		7777 NW BEACON SQUARE BLVD
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		561-826-3620

	MAIL ADDRESS:	
		STREET 1:		7777 NW BEACON SQUARE BLVD
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>eresu-def14a_20220725.htm
<DESCRIPTION>DEF 14A
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
eresu-def14a_20220725.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:12pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:10pt;text-indent:0%;font-size:16pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</p>
<p style="margin-top:0pt;margin-bottom:6pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:left;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:10pt;margin-top:0pt;margin-left:42.31%;margin-right:42.31%;text-indent:0%;font-size:8pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:10pt;text-indent:0%;font-size:16pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE 14A</p>
<p style="margin-top:0pt;margin-bottom:6pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Proxy Statement Pursuant to Section&#160;14(a) of the<br />Securities Exchange Act of 1934</p>
<p style="text-align:left;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:10pt;margin-top:0pt;margin-left:42.31%;margin-right:42.31%;text-indent:0%;font-size:8pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed by the Registrant <font style="font-family:Segoe UI Symbol;">&#9746;</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed by a party other than the Registrant <font style="font-family:Segoe UI Symbol;">&#9744;</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box:</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<font style="font-family:Times New Roman;margin-left:36pt;">Preliminary Proxy Statement</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<font style="font-family:Times New Roman;margin-left:36pt;">Confidential, for Use of the Commission Only (as permitted by Rule 14a</font><font style="font-family:Times New Roman;">&#8209;6(e)(2))</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;<font style="font-family:Times New Roman;margin-left:36pt;">Definitive Proxy Statement</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<font style="font-family:Times New Roman;margin-left:36pt;">Definitive Additional Materials</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<font style="font-family:Times New Roman;margin-left:36pt;">Soliciting Material under &#167;240.14a</font><font style="font-family:Times New Roman;">&#8209;12</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:10pt;text-indent:0%;font-size:16pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">East Resources Acquisition Company</p>
<p style="margin-top:0pt;margin-bottom:6pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Name of Registrant as Specified In Its Charter)</p>
<p style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of Filing Fee (Check all boxes that apply):</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;<font style="font-family:Times New Roman;margin-left:36pt;">No fee required</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<font style="font-family:Times New Roman;margin-left:36pt;">Fee paid previously with preliminary materials</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<font style="font-family:Times New Roman;margin-left:36pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a</font><font style="font-family:Times New Roman;">&#8209;6(i)(1) and 0&#8209;11</font></p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:left;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:normal;color:#EF473E;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> &nbsp;&nbsp;&nbsp;&nbsp; <div></div> &nbsp;&nbsp;&nbsp;&nbsp; <div></div> <font style="color:#808080;font-weight:bold;"> </font> <div></div></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EAST RESOURCES ACQUISITION COMPANY</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7777 NW Beacon Square Boulevard<br />Boca Raton, Florida 33487</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NOTICE OF SPECIAL MEETING</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TO BE HELD ON JULY 25, 2022</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TO THE STOCKHOLDERS OF EAST RESOURCES ACQUISITION COMPANY:</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You are cordially invited to attend the special meeting (the &#8220;<font style="font-weight:bold;font-style:italic;">special meeting</font>&#8221;) of stockholders of East Resources Acquisition Company (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>,&#8221; &#8220;<font style="font-weight:bold;font-style:italic;">we</font>,&#8221; &#8220;<font style="font-weight:bold;font-style:italic;">us</font>&#8221; or &#8220;<font style="font-weight:bold;font-style:italic;">our</font>&#8221;), to be held at 10:00 a.m. Eastern Time, on July 25, 2022.&nbsp;&nbsp;The special meeting will be held virtually, at https://www.cstproxy.com/eastresources/2022.&nbsp;&nbsp;At the special meeting, the stockholders will consider and vote upon the following proposals:</p> <div></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">To amend (the &#8220;<font style="font-weight:bold;font-style:italic;">Extension Amendment</font>&#8221;) the Company&#8217;s Amended and Restated Certificate of Incorporation (our &#8220;<font style="font-weight:bold;font-style:italic;">charter</font>&#8221;) to extend the date by which the Company must consummate a business combination (as defined below) (the &#8220;<font style="font-weight:bold;font-style:italic;">Extension</font>&#8221;) from July&#160;27, 2022 (the date that is 24 months from the closing date of the Company&#8217;s initial public offering of units (the &#8220;<font style="font-weight:bold;font-style:italic;">IPO</font>&#8221;)) to January&#160;27, 2023 (the date that is 30 months from the closing date of the IPO) (the &#8220;<font style="font-weight:bold;font-style:italic;">Extended Date</font>&#8221;) (the &#8220;<font style="font-weight:bold;font-style:italic;">Extension Amendment Proposal</font>&#8221;).</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">A proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension (the &#8220;<font style="font-weight:bold;font-style:italic;">Adjournment Proposal</font>&#8221;).</p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each of the Extension Amendment Proposal and the Adjournment Proposal is more fully described in the accompanying proxy statement.&nbsp;&nbsp;Due to health concerns stemming from the COVID&#8209;19 pandemic, and to support the health and well&#8209;being of our stockholders, the special meeting will be a virtual meeting.&nbsp;&nbsp;You will be able to attend and participate in the special meeting online by visiting https://www.cstproxy.com/eastresources/2022.&nbsp;&nbsp;Please see &#8220;<font style="font-style:italic;">Questions and Answers about the Special Meeting &#8212; How do I attend the special meeting?</font>&#8221; for more information.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE EXTENSION AMENDMENT PROPOSAL AND, IF PRESENTED, THE ADJOURNMENT PROPOSAL.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sole purpose of the Extension Amendment Proposal is to provide the Company with sufficient time to complete a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination involving the Company and one or more businesses (a &#8220;<font style="font-weight:bold;font-style:italic;">business combination</font>&#8221;).&nbsp;&nbsp;While we are currently in discussions with respect to a business combination, the Company&#8217;s board of directors (the &#8220;<font style="font-weight:bold;font-style:italic;">Board</font>&#8221;) currently believes that there will not be sufficient time before July 27,&#160;2022 to complete an initial business combination (the &#8220;<font style="font-weight:bold;font-style:italic;">Combination Period</font>&#8221;).&nbsp;&nbsp;Accordingly, our Board believes that the Extension is necessary in order to be able to consummate an initial business combination. Therefore, our Board has determined that it is in the best interests of our stockholders to extend the date by which the Company must consummate a business combination to the Extended Date in order to provide our stockholders with the opportunity to participate in the prospective investment.&nbsp;&nbsp;In the event that we enter into a definitive agreement for an initial business combination prior to the special meeting, we will issue a press release and file a Current Report on Form 8&#8209;K with the United States Securities and Exchange Commission (&#8220;<font style="font-weight:bold;font-style:italic;">SEC</font>&#8221;) announcing the proposed business combination.&nbsp;&nbsp;The purpose of the Adjournment Proposal is to allow the Company to adjourn the special meeting to a later date or dates if we determine that additional time is necessary to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension.</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The affirmative vote of 65% of the Company</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s outstanding Class A common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, par value $0.0001 per share</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-style:italic;">Class A common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-style:italic;">public shares</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and Class&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">B common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, par value $0.0001 per share</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-style:italic;">Class B common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; or </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-style:italic;">founder shares</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> together with the public shares, the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-style:italic;">common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), voting together as a single class, will be required to approve the Extension Amendment Proposal</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pproval of the Extension Amendment Proposal is a condition to the implementation of the Extension</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;I</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n addition, the Company will not proceed with the Extension if the number of redemptions of our public shares causes the Company to have less than $5,000,001 of net tangible assets following approval of the Extension Amendment Proposal.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Adjournment Proposal requires the affirmative vote of the majority of the votes cast by stockholders represented in person (including virtually) or by proxy at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board has fixed the close of business on June 27, 2022 as the record date for determining the Company&#8217;s stockholders entitled to receive notice of and vote at the special meeting and any adjournment thereof.&nbsp;&nbsp;Only holders of record of the Company&#8217;s common stock on that date are entitled to have their votes counted at the special meeting or any adjournment thereof.&nbsp;&nbsp;A complete list of stockholders of record entitled to vote at the special meeting will be available for ten days before the special meeting at the Company&#8217;s principal executive offices for inspection by stockholders during ordinary business hours for any purpose germane to the special meeting.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Extension Amendment Proposal, holders of public shares (&#8220;<font style="font-weight:bold;font-style:italic;">public stockholders</font>&#8221;) may elect to redeem their public shares for a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account established by the Company in connection with its IPO (the &#8220;<font style="font-weight:bold;font-style:italic;">trust account</font>&#8221;) as of two business days prior to such approval, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares (the &#8220;<font style="font-weight:bold;font-style:italic;">Election</font>&#8221;), regardless of whether such public stockholders vote on the Extension Amendment Proposal.&nbsp;&nbsp;However, the Company may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001.&nbsp;&nbsp;If the Extension Amendment Proposal is approved by the requisite vote of stockholders, holders of public shares that do not make the Election will retain the opportunity to have their public shares redeemed in conjunction with the consummation of a business combination, subject to any limitations set forth in our charter, as amended.&nbsp;&nbsp;In addition, public stockholders who do not make the Election would be entitled to have their public shares redeemed for cash if the Company has not completed a business combination by the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, our sponsor, East Sponsor, LLC, a Delaware limited liability company (our &#8220;<font style="font-weight:bold;font-style:italic;">Sponsor</font>&#8221;), or its designee, has agreed to advance to us as a loan (i) $0.033 for each public share that is not redeemed in connection with the special meeting plus (ii) $0.033  for each public share that is not redeemed for each subsequent calendar month commencing on August 27, 2022, and on the 27th day of each subsequent month, or portion thereof, that we require to complete a business combination from July 27, 2022 until the Extended Date. For example, if we complete the business combination on January 27, 2023, which would represent six calendar months, our Sponsor or its designee would make aggregate maximum advances of approximately $0.198 per share (assuming no public shares were redeemed). Assuming the Extension Amendment Proposal is approved, the initial contribution will be deposited in the trust account promptly following the special meeting. Each additional contribution will be deposited in the trust account on or before the 27th day of such calendar month.&nbsp;&nbsp;Accordingly, if the Extension Amendment Proposal is approved and the Extension is implemented and we take the full time through the Extended Date to complete a business combination, the redemption amount per share at the meeting for such business combination or the Company&#8217;s subsequent liquidation will be approximately $10.199 per share, in comparison to the current redemption amount of $10.01 per share. The advances are conditioned upon the implementation of the Extension Amendment Proposal and will not occur if the Extension Amendment Proposal is not approved or the Extension is not completed. The amount of the advances will not bear interest and will be repayable by the Company to our Sponsor or its designees upon consummation of the business combination.  At the option of the Sponsor, up to $1,500,000 of the loan may be converted into warrants identical to the warrants sold in the private placement that was consummated simultaneously with our IPO, at $1.50 per warrant.  If our Sponsor or its designee advises the Company that it does not intend to make the advances, then the Extension Amendment Proposal and the Adjournment Proposal will not be put before the shareholders at the special meeting and we will dissolve and liquidate in accordance with our charter.  Our Sponsor or its designees will have the sole discretion whether to continue extending for additional calendar months until the Extended Date and if our Sponsor determines not to continue extending for additional calendar months, its obligation to make additional advances will terminate.</p> <div></div>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates that the per share price at which the public shares may be redeemed from cash held in the trust account will be approximately $10.01 at the time of the special meeting.&nbsp;&nbsp;The closing price of the Company&#8217;s Class A common stock on the Nasdaq Stock Market LLC (&#8220;<font style="font-weight:bold;font-style:italic;">NASDAQ</font>&#8221;) on June 27, 2022, the record date of the special meeting, was $9.98.&nbsp;&nbsp;Accordingly, if the market price were to remain the same until the date of the special meeting, exercising redemption rights would result in a public stockholder receiving approximately $0.03 more than if such stockholder sold the public shares in the open market.&nbsp;&nbsp;The Company cannot assure public stockholders that they will be able to sell their public shares in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such stockholders wish to sell their shares.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Adjournment Proposal, if adopted, will allow our Board to adjourn the special meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies.&nbsp;&nbsp;The Adjournment Proposal will be presented to our stockholders only in the event that there are insufficient for, or otherwise in connection with, the approval of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company does not consummate an initial business combination within the Combination Period, as contemplated by our IPO prospectus and in accordance with our charter, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no redemption rights or liquidating distributions with respect to our warrants, including the warrants included in the units sold in the IPO (the &#8220;<font style="font-weight:bold;font-style:italic;">public warrants</font>&#8221;), which will expire worthless in the event the Company winds up.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">You are not being asked to vote on a business combination at this time.&nbsp;&nbsp;If the Extension is implemented and you do not elect to redeem your public shares in connection with the Extension, you will retain the right to vote on a business combination when it is submitted to the public stockholders (provided that you are a stockholder on the record date for a meeting to consider a business combination) and the right to redeem your public shares for a pro rata portion of the trust account in the event a business combination is approved and completed or the Company has not consummated a business combination by the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">After careful consideration of all relevant factors, our Board has determined that the Extension Amendment Proposal and, if presented, the Adjournment Proposal are both advisable and recommends that you vote or give instruction to vote &#8220;FOR&#8221; both the Extension Amendment Proposal and, if presented, the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Enclosed is the proxy statement containing detailed information concerning the Extension Amendment Proposal, Adjournment Proposal and the special meeting.&nbsp;&nbsp;Whether or not you plan to attend the special meeting, the Company urges you to read this material carefully and vote your shares.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:49.95%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 1, 2022</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By Order of the Board of Directors,</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Terrence M. Pegula</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Terrence M. Pegula</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer, President and Chairman</p></td>
</tr>
</table></div> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Your vote is important.&nbsp;&nbsp;If you are a stockholder of record, please sign, date and return your proxy card as soon as possible to make sure that your shares are represented at the special meeting.&nbsp;&nbsp;If you are a stockholder of record, you may also cast your vote virtually at the special meeting.&nbsp;&nbsp;If your shares are held in an account at a brokerage firm or bank, you must instruct your broker or bank how to vote your shares, or </p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">you may cast your vote virtually at the special meeting by obtaining a proxy from your brokerage firm or bank</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Y</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">our failure to vote or instruct your broker or bank how to vote will have the same effect as voting against the Extension Amendment Proposal, and an abstention will have the same effect as voting against the Extension Amendment Proposal</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">bstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the outcome of the Adjournment Proposal.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be held on July 25, 2022: <font style="font-weight:normal;">This notice of meeting and the accompanying proxy statement are available at https://www.cstproxy.com/eastresources/2022.</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST (1) IF YOU HOLD PUBLIC SHARES THROUGH UNITS, ELECT TO SEPARATE YOUR UNITS INTO THE UNDERLYING PUBLIC SHARES AND PUBLIC WARRANTS PRIOR TO EXERCISING YOUR REDEMPTION RIGHTS WITH RESPECT TO THE PUBLIC SHARES, (2) SUBMIT A WRITTEN REQUEST TO THE TRANSFER AGENT BY 5:00&#160;P.M. ON JULY 21, 2022, THE DATE THAT IS TWO BUSINESS DAYS PRIOR TO THE SCHEDULED VOTE AT THE SPECIAL MEETING, THAT YOUR PUBLIC SHARES BE REDEEMED FOR CASH, INCLUDING THE LEGAL NAME, PHONE NUMBER, AND ADDRESS OF THE BENEFICIAL OWNER OF THE SHARES FOR WHICH REDEMPTION IS REQUESTED, AND (3) DELIVER YOUR SHARES OF CLASS A COMMON STOCK TO THE TRANSFER AGENT, PHYSICALLY OR ELECTRONICALLY USING THE DEPOSITORY TRUST COMPANY&#8217;S DWAC (DEPOSIT WITHDRAWAL AT CUSTODIAN) SYSTEM, IN EACH CASE IN ACCORDANCE WITH THE PROCEDURES AND DEADLINES DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT.&nbsp;&nbsp;IF YOU HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BANK OR BROKER TO WITHDRAW THE SHARES FROM YOUR ACCOUNT IN ORDER TO EXERCISE YOUR REDEMPTION RIGHTS.</p> <div></div>
<p style="text-align:left;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p> <a name="_AEIOULastRenderedPageBreakAEIOU2"></a>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PROXY STATEMENT &#8212; DATED JULY 1, 2022</p> <div></div>
<p style="margin-bottom:0pt;margin-top:10pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EAST RESOURCES ACQUISITION COMPANY<br />7777 NW Beacon Square Boulevard</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Boca Raton, Florida 33487</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TO BE HELD ON JULY 25, 2022</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The special meeting of stockholders (the &#8220;<font style="font-weight:bold;font-style:italic;">special meeting</font>&#8221;) of East Resources Acquisition Company (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>,&#8221; &#8220;<font style="font-weight:bold;font-style:italic;">we</font>,&#8221; &#8220;<font style="font-weight:bold;font-style:italic;">us</font>&#8221; or &#8220;<font style="font-weight:bold;font-style:italic;">our</font>&#8221;), a Delaware corporation, will be held at 10:00 a.m. Eastern Time, on July 25, 2022.&nbsp;&nbsp;The special meeting will be held virtually, at https://www.cstproxy.com/eastresources/2022.&nbsp;&nbsp;At the special meeting, the stockholders will consider and vote upon the following proposals:</p> <div></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">To amend (the &#8220;<font style="font-weight:bold;font-style:italic;">Extension Amendment</font>&#8221;) the Company&#8217;s Amended and Restated Certificate of Incorporation (our &#8220;<font style="font-weight:bold;font-style:italic;">charter</font>&#8221;) to extend the date by which the Company must consummate a business combination (as defined below) (the &#8220;<font style="font-weight:bold;font-style:italic;">Extension</font>&#8221;) from July&#160;27, 2022 (the date that is 24 months from the closing date of the Company&#8217;s initial public offering of units (the &#8220;<font style="font-weight:bold;font-style:italic;">IPO</font>&#8221;)) to January&#160;27, 2023 (the date that is 30 months from the closing date of the IPO) (the &#8220;<font style="font-weight:bold;font-style:italic;">Extended Date</font>&#8221;) (the &#8220;<font style="font-weight:bold;font-style:italic;">Extension Amendment Proposal</font>&#8221;).</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">A proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension (the &#8220;<font style="font-weight:bold;font-style:italic;">Adjournment Proposal</font>&#8221;).</p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each of the Extension Amendment Proposal and the Adjournment Proposal is more fully described herein.&nbsp;&nbsp;Due to health concerns stemming from the COVID&#8209;19 pandemic, and to support the health and well&#8209;being of our stockholders, the special meeting will be a virtual meeting.&nbsp;&nbsp;You will be able to attend and participate in the special meeting online by visiting https://www.cstproxy.com/eastresources/2022.&nbsp;&nbsp;Please see &#8220;<font style="font-style:italic;">Questions and Answers about the Special Meeting &#8212; How do I attend the special meeting?</font>&#8221; for more information.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sole purpose of the Extension Amendment Proposal is to provide the Company with sufficient time to complete a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination involving the Company and one or more businesses (a &#8220;<font style="font-weight:bold;font-style:italic;">business combination</font>&#8221;).&nbsp;&nbsp;While we are currently in discussions with respect to a business combination, the Company&#8217;s board of directors (the &#8220;<font style="font-weight:bold;font-style:italic;">Board</font>&#8221;) currently believes that there will not be sufficient time before July 27,&#160;2022 to complete an initial business combination (the &#8220;<font style="font-weight:bold;font-style:italic;">Combination Period</font>&#8221;).&nbsp;&nbsp;Accordingly, our Board believes that the Extension is necessary in order to be able to consummate an initial business combination. Therefore, our Board has determined that it is in the best interests of our stockholders to extend the date by which the Company must consummate a business combination to the Extended Date in order to provide our stockholders with the opportunity to participate in the prospective investment.&nbsp;&nbsp;In the event that we enter into a definitive agreement for an initial business combination prior to the special meeting, we will issue a press release and file a Current Report on Form 8&#8209;K with the United States Securities and Exchange Commission (&#8220;<font style="font-weight:bold;font-style:italic;">SEC</font>&#8221;) announcing the proposed business combination.&nbsp;&nbsp;The purpose of the Adjournment Proposal is to allow the Company to adjourn the special meeting to a later date or dates if we determine that additional time is necessary to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The affirmative vote of 65% of the Company&#8217;s outstanding Class A common stock (&#8220;<font style="font-weight:bold;font-style:italic;">Class A common stock</font>&#8221; or the &#8220;<font style="font-weight:bold;font-style:italic;">public shares</font>&#8221;) and Class&#160;B common stock (&#8220;<font style="font-weight:bold;font-style:italic;">Class B common stock</font>&#8221; or the &#8220;<font style="font-weight:bold;font-style:italic;">founder shares</font>&#8221; and, together with the public shares, the &#8220;<font style="font-weight:bold;font-style:italic;">common stock</font>&#8221;), voting together as a single class, will be required to approve the Extension Amendment Proposal.&nbsp;&nbsp;Approval of the Extension Amendment Proposal is a condition to the implementation of the Extension.&nbsp;&nbsp;In addition, the Company will not proceed with the Extension if the number of redemptions of our public </p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shares causes the Company to have less than $5,000,001 of net tangible assets following approval of the Extension Amendment Proposal.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Adjournment Proposal requires the affirmative vote of the majority of the votes cast by stockholders represented in person (including virtually) or by proxy at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board has fixed the close of business on June 27, 2022 as the record date for determining the Company&#8217;s stockholders entitled to receive notice of and vote at the special meeting and any adjournment thereof.&nbsp;&nbsp;Only holders of record of the Company&#8217;s common stock on that date are entitled to have their votes counted at the special meeting or any adjournment thereof.&nbsp;&nbsp;A complete list of stockholders of record entitled to vote at the special meeting will be available for ten days before the special meeting at the Company&#8217;s principal executive offices for inspection by stockholders during ordinary business hours for any purpose germane to the special meeting.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Extension Amendment Proposal, holders of public shares (&#8220;<font style="font-weight:bold;font-style:italic;">public stockholders</font>&#8221;) may elect to redeem their public shares for a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account established by the Company in connection with its IPO (the &#8220;<font style="font-weight:bold;font-style:italic;">trust account</font>&#8221;) as of two business days prior to such approval, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares (the &#8220;<font style="font-weight:bold;font-style:italic;">Election</font>&#8221;), regardless of whether such public stockholders vote on the Extension Amendment Proposal.&nbsp;&nbsp;However, the Company may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001.&nbsp;&nbsp;If the Extension Amendment Proposal is approved by the requisite vote of stockholders, the holders of public shares that do not make the Election will retain the opportunity to have their public shares redeemed in conjunction with the consummation of a business combination, subject to any limitations set forth in our charter, as amended.&nbsp;&nbsp;In addition, public stockholders who do not make the Election would be entitled to have their public shares redeemed for cash if the Company has not completed a business combination by the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, our sponsor, East Sponsor, LLC, a Delaware limited liability company (our &#8220;<font style="font-weight:bold;font-style:italic;">Sponsor</font>&#8221;), or its designee, has agreed to advance to us as a loan (i) $0.033 for each public share that is not redeemed in connection with the special meeting plus (ii) $0.033 for each public share that is not redeemed for each subsequent calendar month commencing on August 27, 2022, and on the 27th day of each subsequent month, or portion thereof, that we require to complete a business combination from July 27, 2022 until the Extended Date. For example, if we complete the business combination on January 27, 2023, which would represent six calendar months, our Sponsor or its designee would make aggregate maximum advances of approximately $0.198 per share (assuming no public shares were redeemed). Assuming the Extension Amendment Proposal is approved, the initial contribution will be deposited in the trust account promptly following the special meeting. Each additional contribution will be deposited in the trust account on or before the 27th day of such calendar month.&nbsp;&nbsp;Accordingly, if the Extension Amendment Proposal is approved and the Extension is implemented and we take the full time through the Extended Date to complete a business combination, the redemption amount per share at the meeting for such business combination or the Company&#8217;s subsequent liquidation will be approximately $10.199 per share, in comparison to the current redemption amount of $10.01 per share. The advances are conditioned upon the implementation of the Extension Amendment Proposal and will not occur if the Extension Amendment Proposal is not approved or the Extension is not completed. The amount of the advances will not bear interest and will be repayable by the Company to our Sponsor or its designees upon consummation of the business combination.&nbsp;&nbsp;At the option of the Sponsor, up to $1,500,000 of the loan may be converted into warrants identical to the warrants sold in the private placement that was consummated simultaneously with our IPO, at $1.50 per warrant.  If our Sponsor or its designee advises the Company that it does not intend to make the advances, then the Extension Amendment Proposal and the Adjournment Proposal will not be put before the shareholders at the special meeting and we will dissolve and liquidate in accordance with our charter.&nbsp;&nbsp;Our Sponsor or its designees will have the sole discretion whether to continue extending for additional calendar months until the Extended Date and if our Sponsor determines not to continue extending for additional calendar months, its obligation to make additional advances will terminate.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The withdrawal of funds from the trust account in connection with the Election will reduce the amount held in the trust account following the Election, and the amount remaining in the trust account after such withdrawal may be only a fraction of the $345,433,069.01 (including interest, but less the funds used to pay taxes) that was in the trust account as of the record date.&nbsp;&nbsp;In such event, the Company may still seek to obtain additional funds to complete a business combination, and there can be no assurance that such funds will be available on terms acceptable to the parties or at all.</p> <div></div>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates that the per share price at which the public shares may be redeemed from cash held in the trust account will be approximately $10.01 at the time of the special meeting.&nbsp;&nbsp;The closing price of the Company&#8217;s Class A common stock on the Nasdaq Stock Market LLC (&#8220;<font style="font-weight:bold;font-style:italic;">NASDAQ</font>&#8221;) on June 27, 2022, the record date of the special meeting, was $9.98.&nbsp;&nbsp;Accordingly, if the market price were to remain the same until the date of the special meeting, exercising redemption rights would result in a public stockholder receiving approximately $0.03 more than if such stockholder sold the public shares in the open market.&nbsp;&nbsp;The Company cannot assure public stockholders that they will be able to sell their public shares in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such stockholders wish to sell their shares.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Adjournment Proposal, if adopted, will allow our Board to adjourn the special meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies.&nbsp;&nbsp;The Adjournment Proposal will be presented to our stockholders only in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company does not consummate an initial business combination within the Combination Period, as contemplated by our IPO prospectus and in accordance with charter, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless in the event the Company winds up.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">East Sponsor, LLC, a Delaware limited liability company (our &#8220;<font style="font-weight:bold;font-style:italic;">Sponsor</font>&#8221;), officers and directors (altogether the &#8220;<font style="font-weight:bold;font-style:italic;">initial stockholders</font>&#8221;) have agreed to waive their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to the Company&#8217;s charter.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended.&nbsp;&nbsp;However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have we independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and believe that our Sponsor&#8217;s only assets are securities of the Company.&nbsp;&nbsp;Therefore, we cannot assure that its Sponsor would be able to satisfy those obligations.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Delaware General Corporation Law (the &#8220;<font style="font-weight:bold;font-style:italic;">DGCL</font>&#8221;), stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution.&nbsp;&nbsp;If the corporation complies with certain procedures set forth in Section&#160;280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60&#8209;day notice period during which any third&#8209;party claims can be brought against the corporation, a 90&#8209;day period during which the corporation may reject any claims brought, and an additional 150&#8209;day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder&#8217;s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">However, because the Company will not be complying with </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280 of the DGCL, </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281(b) of the DGCL requires the Company to adopt a plan, based on facts known to the Company at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against the Company within the subsequent ten years following our dissolution</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">owever, because the Company is a blank check company, rather than an operating company, and our operations have been limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, such approval will constitute consent for the Company to (i)&#160;remove from the trust account an amount (the &#8220;<font style="font-weight:bold;font-style:italic;">Withdrawal Amount</font>&#8221;) equal to the number of public shares properly redeemed multiplied by the per share price, equal to the aggregate amount then on deposit in the trust account as of two business days prior to such approval, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares and (ii)&#160;deliver to the holders of such redeemed public shares their portion of the Withdrawal Amount.&nbsp;&nbsp;The remainder of such funds shall remain in the trust account and be available for use by the Company to complete a business combination on or before the Extended Date.&nbsp;&nbsp;Holders of public shares who do not redeem their public shares now will retain their redemption rights and their ability to vote on a business combination through the Extended Date if the Extension Amendment Proposal is approved.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board has fixed the close of business on June 27, 2022 as the date for determining the Company stockholders entitled to receive notice of and vote at the special meeting.&nbsp;&nbsp;Only record holders of the Company&#8217;s common stock at the close of business on the record date are entitled to vote or have their votes cast at the special meeting.&nbsp;&nbsp;On the record date, there were 34,500,000 outstanding shares of the Company&#8217;s Class A common stock and 8,625,000  outstanding shares of the Company&#8217;s Class B common stock, which vote together as a single class with respect to the Extension Amendment Proposal.&nbsp;&nbsp;The Company&#8217;s warrants do not have voting rights in connection with either the Extension Amendment Proposal or, if presented, the Adjournment Proposal.</p> <div></div>
<p style="margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This proxy statement contains important information about the special meeting and the proposals to be voted on at the special meeting.&nbsp;&nbsp;Please read it carefully and vote your shares.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#FORWARDLOOKING_STATEMENTS"><font style="text-decoration:none;">FORWARD&#8209;LOOKING STATEMENTS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#QUESTIONS_ANSWERS_ABOUT_SPECIAL_MEETING"><font style="text-decoration:none;">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#SPECIAL_MEETING"><font style="text-decoration:none;">THE SPECIAL MEETING</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#DATE_TIME_PLACE_PURPOSE__SPECIAL_MEETING"><font style="text-decoration:none;">Date, Time, Place and Purpose of the Special Meeting</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#VOTING_POWER_RECORD_DATE"><font style="text-decoration:none;">Voting Power; Record Date</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#VOTES_REQUIRED"><font style="text-decoration:none;">Votes Required</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#VOTING"><font style="text-decoration:none;">Voting</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#REVOCABILITY_PROXIES"><font style="text-decoration:none;">Revocability of Proxies</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#ATTENDANCE_AT_SPECIAL_MEETING"><font style="text-decoration:none;">Attendance at the Special Meeting</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#SOLICITATION_PROXIES"><font style="text-decoration:none;">Solicitation of Proxies</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#NO_RIGHT_APPRAISAL"><font style="text-decoration:none;">No Right of Appraisal</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#OR_BUSINESS"><font style="text-decoration:none;">Other Business</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#PRINCIPAL_EXECUTIVE_FICES"><font style="text-decoration:none;">Principal Executive Offices</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#EXTENSION_AMENDMENT_PROPOSAL"><font style="text-decoration:none;">THE EXTENSION AMENDMENT PROPOSAL</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#BACKGROUND"><font style="text-decoration:none;">Background</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#EXTENSION_AMENDMENT"><font style="text-decoration:none;">The Extension Amendment</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#REASONS_FOR_PROPOSAL"><font style="text-decoration:none;">Reasons for the Proposal</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#IF_EXTENSION_AMENDMENT_PROPOSAL_IS_NOT_A"><font style="text-decoration:none;">If the Extension Amendment Proposal is Not Approved</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#IF_EXTENSION_AMENDMENT_PROPOSAL_IS_APPRO"><font style="text-decoration:none;">If the Extension Amendment Proposal is Approved</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#REDEMPTION_RIGHTS"><font style="text-decoration:none;">Redemption Rights</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#INTERESTS__COMPANYS_DIRECTORS_EXECUTIVE_"><font style="text-decoration:none;">Interests of the Company&#8217;s Directors and Executive Officers</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#US_FEDERAL_INCOME_TAX_CONS"><font style="text-decoration:none;">U.S. Federal Income Tax Considerations</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#US_HOLDERS"><font style="text-decoration:none;">U.S. Holders</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#INFORMATION_REPORTING_BACKUP_WITHHOLDING"><font style="text-decoration:none;">Information Reporting and Backup Withholding</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#NONUS_HOLDERS"><font style="text-decoration:none;">Non&#8209;U.S. Holders</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#INFORMATION_REPORTING_BACKUP_W"><font style="text-decoration:none;">Information Reporting and Backup Withholding</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#FOREIGN_ACCOUNT_TAX_COMPLIANCE_ACT"><font style="text-decoration:none;">Foreign Account Tax Compliance Act</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#REQUIRED_VOTE"><font style="text-decoration:none;">Required Vote</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#RECOMMENDATION"><font style="text-decoration:none;">Recommendation</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#ADJOURNMENT_PROPOSAL"><font style="text-decoration:none;">THE ADJOURNMENT PROPOSAL</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#OVERVIEW"><font style="text-decoration:none;">Overview</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#CONSEQUENCES_IF_ADJOURNMENT_PROPOSAL_IS_"><font style="text-decoration:none;">Consequences if the Adjournment Proposal is Not Approved</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#REQUIRED_VO"><font style="text-decoration:none;">Required Vote</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr>
<td valign="top"  style="width:7.7%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:85.88%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#RECOMMENDAT"><font style="text-decoration:none;">Recommendation</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#PRINCIPAL_STOCKHOLDERS"><font style="text-decoration:none;">PRINCIPAL STOCKHOLDERS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#DELIVERY_DOCUMENTS_TO_STOCKHOLDERS"><font style="text-decoration:none;">DELIVERY OF DOCUMENTS TO STOCKHOLDERS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;text-transform:none;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#WHERE_YOU_CAN_FIND_MORE_INFORMATION"><font style="text-decoration:none;">WHERE YOU CAN FIND MORE INFORMATION</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:93.58%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;text-transform:uppercase;font-family:Times New Roman;font-variant: normal;font-size:10pt;font-weight:normal;font-style:normal;"><a href="#ANNEX_A"><font style="text-decoration:none;">Annex A</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.3%;">
<p style="margin-bottom:0pt;margin-top:3pt;text-align:justify;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:3pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A-1</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431829"></a><a name="FORWARDLOOKING_STATEMENTS"></a>FORWARD-<a name="FORWARDLOOKING_STATEMENTS"></a>LOOKING STATEMENTS</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The statements contained in this proxy statement that are not purely historical are &#8220;forward&#8209;looking statements.&#8221;&nbsp;&nbsp;Our forward&#8209;looking statements include, but are not limited to, statements regarding our or our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future.&nbsp;&nbsp;In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward&#8209;looking statements.&nbsp;&nbsp;The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions may identify forward&#8209;looking statements, but the absence of these words does not mean that a statement is not forward&#8209;looking.&nbsp;&nbsp;Forward&#8209;looking statements in this proxy statement may include, without limitation, statements about:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our ability to select an appropriate target business or businesses;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our ability to complete our initial business combination;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our ability to consummate an initial business combination due to the uncertainty resulting from the COVID-19 pandemic (&#8220;COVID-19&#8221;) and economic uncertainty and volatility in the financial markets, including as a result of the military conflict in Ukraine;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our expectations around the performance of the prospective target business or businesses;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our potential ability to obtain additional financing to complete our initial business combination;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our pool of prospective target businesses;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">failure to maintain the listing on, or the delisting of our securities from, the Nasdaq Stock Market LLC (&#8220;NASDAQ&#8221;) or an inability to have our securities listed on NASDAQ or another national securities exchange following our initial business combination;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">the ability of our officers and directors to generate a number of potential acquisition opportunities;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our public securities&#8217; potential liquidity and trading;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">the lack of a market for our securities;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">the use of proceeds not held in the trust account (the &#8220;trust account&#8221;) or available to us from interest income on the trust account balance;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">the trust account not being subject to claims of third parties; or</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">our financial performance.</font></p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The forward&#8209;looking statements contained in this proxy statement are based on our current expectations and beliefs concerning future developments and their potential effects on us.&nbsp;&nbsp;There can be no assurance that future developments affecting us will be those that we have anticipated.&nbsp;&nbsp;These forward&#8209;looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward&#8209;looking statements.&nbsp;&nbsp;These risks and uncertainties include, but are not limited to, those factors described under the heading &#8220;Risk Factors&#8221; in our Final Prospectus on Form 424(b)(3) filed with the SEC on July 24, 2020 and subsequent </p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">periodic filings with the SEC</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hould one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;looking statements</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;W</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e undertake no obligation to update or revise any forward</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</font></p><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="QUESTIONS_ANSWERS_ABOUT_SPECIAL_MEETING"></a><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="QUESTIONS_ANSWERS_ABOUT_SPECIAL_MEETING"></a>QUESTIONS AND ANSWERS AB</font><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">OUT THE SPECIAL MEETING</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These Questions and Answers are only summaries of the matters they discuss.&nbsp;&nbsp;They do not contain all of the information that may be important to you.&nbsp;&nbsp;You should read carefully the entire document, including the annexes to this proxy statement.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Why am I receiving this proxy statement?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This proxy statement and the enclosed proxy card are being sent to you in connection with the solicitation of proxies by our Board for use at the special meeting, or at any adjournments thereof.&nbsp;&nbsp;This proxy statement summarizes the information that you need to make an informed decision on the proposals to be considered at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is a blank check company formed in 2020 for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.&nbsp;&nbsp;On July 27, 2020, the Company consummated its IPO of 30,000,000 units (the &#8220;<font style="font-weight:bold;font-style:italic;">initial units</font>&#8221;).&nbsp;&nbsp;On August 25, 2020, the Company consummated the full exercise of the underwriters&#8217; 4,500,000 unit over-allotment option (together with the initial units, the &#8220;<font style="font-weight:bold;font-style:italic;">units</font>&#8221;).&nbsp;&nbsp;Each unit consists of one share of Class A common stock (the &#8220;<font style="font-weight:bold;font-style:italic;">public shares</font>&#8221;) and one&#8209;half of one redeemable warrant (the &#8220;<font style="font-weight:bold;font-style:italic;">public warrants</font>&#8221;).  The units were sold at an offering price of $10.00 per unit, generating gross proceeds of $345,000,000.  Simultaneously with the closing of the IPO, the Company consummated the sale of an aggregate of 8,000,000 private placement warrants (the &#8220;<font style="font-weight:bold;font-style:italic;">initial</font><font style="font-style:italic;"> </font><font style="font-weight:bold;font-style:italic;">private placement warrants</font>&#8221;) at a price of $1.00 per warrant in a private placement to our Sponsor, generating gross proceeds to the Company of $8,000,000.  Simultaneously with the consummation of the full exercise of the underwriters&#8217; over-allotment option, the Company consummated a sale of an additional 900,000 private placement warrants (the &#8220;<font style="font-weight:bold;font-style:italic;">additional private placement warrants</font>&#8221; and together with the initial private public warrants, the &#8220;<font style="font-weight:bold;font-style:italic;">private placement warrants</font>&#8221;) our sponsor generating additional proceeds of $900,000.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following the closing of the IPO on July&#160;27, 2020, an amount of $300,000,000 ($10.00 per unit) from the net proceeds of the sale of the units in the IPO and the sale of the initial private placement warrants was placed in the trust account.  Following the full exercise of the underwriter&#8217;s over-allotment option, an amount of $45,000,000 ($10.00 per unit) from the net proceeds of the over-allotment and the sale of the additional private placement warrants was placed in the trust account.  The trust account was invested in U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a&#8209;7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (a) the completion of the Company&#8217;s initial business combination, (b) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company&#8217;s charter, and (c) the redemption of the Company&#8217;s public shares if the Company is unable to complete the initial business combination within the Combination Period (as defined below).&nbsp;&nbsp;Like most blank check companies, our charter provides for the return of the IPO proceeds held in the trust account to the holders of shares of common stock sold in the IPO if there is no qualifying business combination(s) consummated on or before a certain date (the &#8220;<font style="font-weight:bold;font-style:italic;">Combination Period</font>&#8221;).&nbsp;&nbsp;In our case such certain date is July&#160;27, 2022.&nbsp;&nbsp;Our Board has determined that it is in the best interests of the Company to amend the Company&#8217;s charter to extend the date we have to consummate a business combination to January&#160;27, 2023 in order to allow the Company more time to complete a business combination.&nbsp;&nbsp;Therefore, our Board is submitting the proposals described in this proxy statement for the stockholders to vote upon.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What is being voted on?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You are being asked to vote on each of the Extension Amendment Proposal and, if presented, the Adjournment Proposal.&nbsp;&nbsp;Both proposals are listed below:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;">Extension Amendment Proposal:</font> To amend our charter to extend the date by which the Company must consummate a business combination from July 27, 2022 (the date that is 24 months from the closing date of the IPO) to January 27, 2023 (the date that is 30 months from the closing date of the IPO).</p></td></tr></table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;">Adjournment Proposal</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">: A proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension.</font></p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What are the purposes of the Extension Amendment Proposal and the Adjournment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sole purpose of the Extension Amendment Proposal is to provide the Company with sufficient time to complete a business combination.&nbsp;&nbsp;While we are currently in discussions with respect to a business combination, the Board currently believes that there will not be sufficient time within the Combination Period to complete an initial business combination.&nbsp;&nbsp;Accordingly, our Board believes that the Extension is necessary in order to be able to consummate an initial business combination. Therefore, our Board has determined that it is in the best interests of our stockholders to extend the date by which the Company must consummate a business combination to the Extended Date in order to provide our stockholders with the opportunity to participate in the prospective investment.&nbsp;&nbsp;In the event that we enter into a definitive agreement for an initial business combination prior to the special meeting, we will issue a press release and file a Current Report on Form 8&#8209;K with the SEC announcing the proposed business combination.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purpose of the Adjournment Proposal is to allow the Company to adjourn the special meeting to a later date or dates if we determine that additional time is necessary to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Extension Amendment Proposal is a condition to the implementation of the Extension.&nbsp;&nbsp;The Company will not proceed with the Extension if redemptions of our public shares cause the Company to have less than $5,000,001 of net tangible assets following approval of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension is implemented, such approval will constitute consent for the Company to remove the Withdrawal Amount from the trust account, deliver to the holders of redeemed public shares their portion of the Withdrawal Amount and retain the remainder of the funds in the trust account for the Company&#8217;s use in connection with consummating a business combination on or before the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved and the Extension is implemented, the removal of the Withdrawal Amount from the trust account in connection with the Election will reduce the amount held in the trust account following the Election.&nbsp;&nbsp;The Company cannot predict the amount that will remain in the trust account after such withdrawal if the Extension Amendment Proposal is approved and the amount remaining in the trust account may be only a fraction of the $345,433,069.01 (including interest but less the funds used to pay taxes) that was in the trust account as of the record date.&nbsp;&nbsp;In such event, the Company may still seek to obtain additional funds to complete a business combination, and there can be no assurance that such funds will be available on terms acceptable to the parties or at all.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company has not consummated an initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to complete an initial business combination within the Combination Period.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Adjournment Proposal will be presented at the special meeting </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">only </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if there are not sufficient votes to approve the Extension Amendment Proposal.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial stockholders have agreed to waive their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to the charter.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Why is the Company proposing the Extension Amendment Proposal and the Adjournment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s charter provides for the return of the IPO proceeds held in trust to the holders of shares of common stock sold in the IPO if there is no qualifying business combination(s) consummated within the Combination Period.&nbsp;&nbsp;While we are currently in discussions with respect to a business combination, the Board currently believes that there will not be sufficient time within the Combination Period to complete an initial business combination.&nbsp;&nbsp;Accordingly, the Company has determined to seek stockholder approval to extend the date by which the Company has to complete the business combination.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sole purpose of the Extension Amendment Proposal is to provide the Company with sufficient time to complete a business combination, which our Board believes is in the best interest of our stockholders.&nbsp;&nbsp;The Company believes that given the Company&#8217;s expenditure of time, effort and money on searching for potential business combination opportunities, including the fact that we are in active discussions regarding a business combination, circumstances warrant providing public stockholders an opportunity to consider an initial business combination.&nbsp;&nbsp;In the event that we enter into a definitive agreement for an initial business combination prior to the special meeting, we will issue a press release and file a Current Report on Form 8&#8209;K with the SEC announcing the proposed business combination.&nbsp;&nbsp;The purpose of the Adjournment Proposal is to allow the Company to adjourn the special meeting to a later date or dates if we determine that additional time is necessary to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension.&nbsp;&nbsp;Accordingly, our Board is proposing the Extension Amendment Proposal and, if necessary, the Adjournment Proposal to extend the Company&#8217;s corporate existence until the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">You are not being asked to vote on any proposed business combination at this time.&nbsp;&nbsp;If the Extension is implemented and you do not elect to redeem your public shares now, you will retain the right to vote on any proposed business combination when and if one is submitted to the public stockholders (provided that you are a stockholder on the record date for a meeting to consider a business combination) and the right to redeem your public shares for a pro rata portion of the trust account in the event a proposed business combination is approved and completed or the Company has not consummated a business combination by the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Why should I vote for the Extension Amendment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board believes stockholders will benefit from the Company consummating a business combination and is proposing the Extension Amendment Proposal to extend the date by which the Company must complete a business combination until the Extended Date.&nbsp;&nbsp;The Extension would give the Company the opportunity to complete a business combination, which our Board believes in the best interests of the stockholders.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our charter provides that if the our stockholders approve an amendment to our charter that would affect the substance or timing of the Company&#8217;s obligation to redeem 100% of the Company&#8217;s public shares if the Company does not complete a business combination within the Combination Period, the Company will provide our public stockholders with the opportunity to redeem all or a portion of their shares of common stock upon such approval at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to such approval, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares.&nbsp;&nbsp;This charter provision was included to protect the Company&#8217;s stockholders from having to sustain their investments for an unreasonably long period if the Company failed to find a suitable business combination in the timeframe contemplated by the charter.&nbsp;&nbsp;The Company also believes, however, that given the Company&#8217;s expenditure of time, effort and money on pursuing a business combination, including the fact that we are in active discussions regarding a business combination, circumstances warrant providing those who believe they might find a business combination to be an attractive investment with an opportunity to consider such transaction.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board recommends that you vote in favor of the Extension Amendment Proposal, but expresses no opinion as to whether you should redeem your public shares.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Why should I vote for the Adjournment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Adjournment Proposal is presented and not approved by our stockholders, our Board may not be able to adjourn the special meeting to a later date in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board recommends that you vote in favor of the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What amount will holders receive upon consummation of a subsequent business combination or liquidation of the Extension Amendment Proposal is approved?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, our Sponsor, or its designee, has agreed to advance to us as a loan (i) $0.033 for each public share that is not redeemed in connection with the special meeting plus (ii) $0.033 for each public share that is not redeemed for each subsequent calendar month commencing on August 27, 2022, and on the 27th day of each subsequent month, or portion thereof, that we require to complete a business combination from July 27, 2022 until the Extended Date. For example, if we complete the business combination on January 27, 2023, which would represent six calendar months, our Sponsor or its designee would make aggregate maximum advances of approximately $0.198 per share (assuming no public shares were redeemed). Assuming the Extension Amendment Proposal is approved, the initial contribution will be deposited in the trust account promptly following the special meeting. Each additional contribution will be deposited in the trust account on or before the 27th day of such calendar month.&nbsp;&nbsp;Accordingly, if the Extension Amendment Proposal is approved and the Extension is implemented and we take the full time through the Extended Date to complete a business combination, the redemption amount per share at the meeting for such business combination or the Company&#8217;s subsequent liquidation will be approximately $10.199 per share, in comparison to the current redemption amount of $10.01 per share. The advances are conditioned upon the implementation of the Extension Amendment Proposal and will not occur if the Extension Amendment Proposal is not approved or the Extension is not completed. The amount of the advances will not bear interest and will be repayable by the Company to our Sponsor or its designees upon consummation of the business combination.&nbsp;&nbsp;At the option of the Sponsor, up to $1,500,000 of the loan may be converted into warrants identical to the warrants sold in the private placement that was consummated simultaneously with our IPO, at $1.50 per warrant.  If our Sponsor or its designee advises the Company that it does not intend to make the advances, then the Extension Amendment Proposal and the Adjournment Proposal will not be put before the shareholders at the special meeting and we will dissolve and liquidate in accordance with our charter.&nbsp;&nbsp;Our Sponsor or its designees will have the sole discretion whether to continue extending for additional calendar months until the Extended Date and if our Sponsor determines not to continue extending for additional calendar months, its obligation to make additional advances will terminate.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">When would the Board abandon the Extension Amendment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board will abandon the Extension Amendment if our stockholders do not approve the Extension Amendment Proposal. In addition, notwithstanding stockholder approval of the Extension Amendment Proposal, our Board will retain the right to abandon and not implement the Extension Amendment at any time without any further action by our stockholders.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How do the Company insiders intend to vote their shares?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial stockholders and their respective affiliates are expected to vote any common stock over which they have voting control (including any public shares owned by them) in favor of both of the proposals.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial stockholders are not entitled to redeem the founder shares or any public shares held by them.&nbsp;&nbsp;On the record date, the initial stockholders beneficially owned and were entitled to vote 8,625,000 founder shares, which represents 20% of the Company&#8217;s issued and outstanding common stock.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company&#8217;s initial stockholders or advisors, or any of their respective affiliates, may purchase public shares in privately negotiated transactions or in the open market prior to or following the special </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">meeting, although they are under no obligation to do so</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">uch public shares purchased by the Company or our Sponsor would be (a) purchased at a price no higher than the redemption price for the public shares, which is currently estimated to be $</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.01</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> per share and (b) would not be (</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) voted by the initial stockholders or their respective affiliates at the special meeting and (ii) redeemable by the initial stockholders or their respective affiliates</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny such purchases that are completed after the record date for the special meeting may include an agreement with a selling stockholder that such stockholder, for so long as it remains the record holder of the shares in question, will vote in favor of the Extension Amendment Proposal and/or will not exercise its redemption rights with respect to the shares so purchased</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;T</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he purpose of such share purchases and other transactions would be to increase the likelihood that the proposals to be voted upon at the special meeting are approved by the requisite number of votes and to reduce the number of public shares that are redeemed</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;I</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n the event that such purchases do occur, the purchasers may seek to purchase shares from stockholders who would otherwise have voted against the Extension Amendment Proposal and elected to redeem their shares for a portion of the trust account</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny such privately negotiated purchases may be effected at purchase prices that are below or in excess of the per</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">share pro rata portion of the trust account</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny public shares held by or subsequently purchased by our affiliates may be voted in favor of the Extension Amendment Proposal</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;N</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">one of the initial stockholders, advisors or their respective affiliates may make any such purchases when they are in possession of any material non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;public information not disclosed to the seller or during a restricted period under Regulation M under the Securities Exchange Act of 1934, as amended (the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-style:italic;">Exchange Act</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">).</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Does the Board recommend voting for the approval of the Extension Amendment Proposal and, if presented, the Adjournment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes.&nbsp;&nbsp;After careful consideration of the terms and conditions of the proposals, the Board has determined that the Extension Amendment Proposal and, if presented, the Adjournment Proposal are in the best interests of the Company and its stockholders.&nbsp;&nbsp;The Board unanimously recommends that stockholders vote &#8220;<font style="font-weight:bold;">FOR</font>&#8221; both the Extension Amendment Proposal and, if presented, the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What vote is required to adopt the Extension Amendment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Extension Amendment Proposal will require the affirmative vote of holders of 65% of the Company&#8217;s outstanding Class A common stock and Class B common stock, voting together as a single class, including those shares held as a constituent part of our units, on the record date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, any holder of public shares may redeem all or a portion of their public shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to such approval, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares.&nbsp;&nbsp;However, the Company may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What vote is required to adopt the Adjournment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If presented, the Adjournment Proposal requires the affirmative vote of the majority of the votes cast by stockholders represented in person (including virtually) or by proxy at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What happens if I sell my public shares or units before the special meeting?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The June 27, 2022 record date is earlier than the date of the special meeting.&nbsp;&nbsp;If you transfer your public shares, including those shares held as a constituent part of our units, after the record date, but before the special meeting, unless the transferee obtains from you a proxy to vote those shares, you will retain your right to vote at the special meeting.&nbsp;&nbsp;If you transfer your public shares prior to the record date, you will have no right to vote those shares at the special meeting.&nbsp;&nbsp;If you acquired your public shares after the record date, you will still have an opportunity to redeem them if you so decide.</p> <div></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What if I don&#8217;t want to vote for the Extension Amendment Proposal and/or the Adjournment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not want the Extension Amendment Proposal to be approved, you must abstain, not vote, or vote against the proposal.&nbsp;&nbsp;If the Extension Amendment Proposal is approved, and the Extension is implemented, then the Withdrawal Amount will be withdrawn from the trust account and paid to the redeeming holders.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not want the Adjournment Proposal to be approved, you must vote against the proposal.&nbsp;&nbsp;Abstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the outcome of the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Will you seek any further extensions to liquidate the trust account?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than the extension until the Extended Date as described in this proxy statement, the Company does not currently anticipate seeking any further extension to consummate its initial business combination, although it may determine to do so in the future.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What happens if the Extension Amendment Proposal is not approved?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company has not consummated an initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to complete an initial business combination within the Combination Period.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial stockholders have agreed to waive their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to the charter.&nbsp;&nbsp;There will be no distribution from the trust account with respect to our warrants, which will expire worthless in the event we wind up.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, what happens next?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, the Company will continue to attempt to consummate an initial business combination until the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, the Company will file an amendment to the charter with the Secretary of State of the State of Delaware in the form of <font style="text-decoration:underline;">Annex A</font> hereto.&nbsp;&nbsp;The Company will remain a reporting company under the Exchange Act, and its units, public shares, and public warrants will remain publicly traded.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, the removal of the Withdrawal Amount from the trust account will reduce the amount remaining in the trust account and increase the percentage interest of the Company&#8217;s common stock held by our initial stockholders through the founder shares.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If I do not redeem my shares now, would I still be able to vote on an initial business combination and exercise my redemption rights with respect to an initial business combination?</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yes.&nbsp;&nbsp;If you do not redeem your shares in connection with the Extension Amendment Proposal, then, assuming you are a stockholder as of the record date for voting on a business combination, you will be able to vote on the business combination when it is submitted to stockholders.&nbsp;&nbsp;You will also retain your right to redeem your public shares upon consummation of a business combination, subject to any limitations set forth in the charter, as amended.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">When and where is the special meeting?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The special meeting will be held at 10:00 a.m. Eastern Time, on July 25, 2022, in virtual format.&nbsp;&nbsp;The Company&#8217;s stockholders may attend, vote and examine the list of stockholders entitled to vote at the special meeting by visiting https://www.cstproxy.com/eastresources/2022 and entering the control number found on their proxy card, voting instruction form or notice included in their proxy materials.&nbsp;&nbsp;You may also attend the special meeting telephonically by dialing 1 800-450-7155 (toll&#8209;free within the United States and Canada) or +1 857-999-9155 (outside of the United States and Canada, standard rates apply).&nbsp;&nbsp;The pin number for telephone access is 4192949#, but please note that you will not be able to vote or ask questions if you choose to participate telephonically.&nbsp;&nbsp;In light of public health concerns regarding the COVID&#8209;19 pandemic, the special meeting will be held in virtual meeting format only.&nbsp;&nbsp;You will not be able to attend the special meeting physically.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How do I attend the virtual special meeting, and will I be able to ask questions?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you are a registered stockholder, you received a proxy card from the Company&#8217;s transfer agent, Continental Stock Transfer &amp; Trust Company (&#8220;<font style="font-weight:bold;font-style:italic;">transfer agent</font>&#8221;).&nbsp;&nbsp;The form contains instructions on how to attend the virtual annual meeting including the URL address, along with your control number.&nbsp;&nbsp;You will need your control number for access.&nbsp;&nbsp;If you do not have your control number, contact the transfer agent at the phone number or e&#8209;mail address below.&nbsp;&nbsp;The transfer agent support contact information is as follows: (917) 262-2373, or email proxy@continentalstock.com.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You can pre&#8209;register to attend the virtual meeting starting July 18, 2022 at 10:00 a.m. Eastern Time (five business days prior to the special meeting date).&nbsp;&nbsp;Enter the URL address into your browser https://www.cstproxy.com/eastresources/2022, enter your control number, name and email address.&nbsp;&nbsp;Once you pre-register you can vote or enter questions in the chat box.&nbsp;&nbsp;At the start of the special meeting you will need to re-log in using your control number and will also be prompted to enter your control number if you vote during the special meeting.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficial holders, who own their investments through a bank or broker, will need to contact the transfer agent to receive a control number.&nbsp;&nbsp;If you plan to vote at the special meeting you will need to have a legal proxy from your bank or broker or if you would like to join and not vote, the transfer agent will issue you a guest control number with proof of ownership.&nbsp;&nbsp;Either way you must contact the transfer agent for specific instructions on how to receive the control number.&nbsp;&nbsp;We can be contacted at the number or email address above.&nbsp;&nbsp;Please allow up to 72 hours prior to the special meeting for processing your control number.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not have internet capabilities, you can listen only to the special meeting by dialing 1 800-450-7155, within the U.S. and Canada, or +1 857-999-9155 (standard rates apply) outside the U.S. and Canada; when prompted enter the pin number 4192949#.&nbsp;&nbsp;This is listen only, you will not be able to vote or enter questions during the special meeting.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How do I vote?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you are a holder of record of Company common stock, including those shares held as a constituent part of our units, you may vote virtually at the special meeting or by submitting a proxy for the special meeting.&nbsp;&nbsp;Whether or not you plan to attend the special meeting virtually, the Company urges you to vote by proxy to ensure your vote is counted.&nbsp;&nbsp;You may submit your proxy by completing, signing, dating and returning the enclosed proxy card in the accompanying pre&#8209;addressed postage paid envelope.&nbsp;&nbsp;You may still attend the special meeting and vote virtually if you have already voted by proxy.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If your shares of Company common stock, including those shares held as a constituent part of our units, are held in </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">street name</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> by a broker or other agent, you have the right to direct your broker or other agent on how to vote the shares in your account</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Y</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ou are also invited to attend the special meeting</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">owever, since you are not the stockholder of record, you may not vote your shares virtually at the special meeting unless you request and obtain a valid proxy from your broker or other agent.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How do I change my vote?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you have submitted a proxy to vote your shares and wish to change your vote, you may do so by delivering a later&#8209;dated, signed proxy card prior to the date of the special meeting or by voting virtually at the special meeting.&nbsp;&nbsp;Attendance at the special meeting alone will not change your vote.&nbsp;&nbsp;You also may revoke your proxy by sending a notice of revocation to the Company at 7777 NW Beacon Square Boulevard, Boca Raton, Florida, 33487, Attn: John Sieminski.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How are votes counted?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Votes will be counted by the inspector of election appointed for the special meeting, who will separately count &#8220;FOR&#8221; and &#8220;AGAINST&#8221; votes, abstentions and broker non&#8209;votes for the Extension Amendment Proposal.&nbsp;&nbsp;Because approval of the Extension Amendment Proposal requires the affirmative vote of the stockholders holding at least 65% of the shares of Class A common stock and Class B common stock outstanding on the record date, voting together as a single class, abstentions and broker non&#8209;votes will have the same effect as votes against the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Adjournment Proposal requires the affirmative vote of the majority of the votes cast by stockholders represented in person (including virtually) or by proxy at the special meeting.&nbsp;&nbsp;Abstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the outcome of the Adjournment Proposal.&nbsp;&nbsp;Since the Adjournment Proposal is considered a routine matter, brokers shall be entitled to vote on the Adjournment Proposal absent voting instructions, and thus there should be no broker non&#8209;votes with respect to the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If my shares are held in &#8220;street name,&#8221; will my broker automatically vote them for me?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No.  Under the rules governing banks and brokers who submit a proxy card with respect to shares held in street name, such banks and brokers have the discretion to vote on routine matters, but not on non&#8209;routine matters.&nbsp;&nbsp;The approval of the Extension Amendment Proposal is a non&#8209;routine matter, while the Adjournment Proposal, if presented, will be considered a routine matter.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For non&#8209;routine matters such as the Extension Amendment Proposal, your broker can vote your shares only if you provide instructions on how to vote.&nbsp;&nbsp;You should instruct your broker to vote your shares.&nbsp;&nbsp;Your broker can tell you how to provide these instructions.&nbsp;&nbsp;If you do not give your broker instructions, your shares will be treated as broker non&#8209;votes with respect to the Extension Amendment Proposal.&nbsp;&nbsp;Broker non&#8209;votes will have the same effect as a vote AGAINST the Extension Amendment Proposal; however, since the Adjournment Proposal is considered a routine matter, brokers shall be entitled to vote on the Adjournment Proposal absent voting instructions, and thus there should be no broker non&#8209;votes with respect to the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What is a quorum requirement?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A quorum of stockholders is necessary to hold a valid meeting.&nbsp;&nbsp;A quorum will be present if at least a majority of the outstanding shares of common stock on the record date, including those shares held as a constituent part of our units, are represented virtually or by proxy at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote virtually at the special meeting.&nbsp;&nbsp;Abstentions and broker non&#8209;votes will be counted towards the quorum requirement.&nbsp;&nbsp;If there is no quorum, the presiding officer of the special meeting may adjourn the special meeting to another date.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Who can vote at the special meeting?</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Only holders of record of the Company&#8217;s common stock, including those shares held as a constituent part of our units, at the close of business on June 27, 2022, are entitled to have their vote counted at the special meeting and any adjournments or postponements thereof.&nbsp;&nbsp;As of the record date, 34,500,000 public shares and 8,625,000 shares of Class B common stock were outstanding and entitled to vote.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stockholder of Record: Shares Registered in Your Name<font style="font-style:normal;">.&nbsp;&nbsp;If on the record date your shares or units were registered directly in your name with the Company&#8217;s transfer agent, Continental Stock Transfer &amp; Trust Company, then you are a stockholder of record.&nbsp;&nbsp;As a stockholder of record, you may vote virtually at the special meeting or vote by proxy.&nbsp;&nbsp;Whether or not you plan to attend the special meeting virtually, the Company urges you to fill out and return the enclosed proxy card to ensure your vote is counted.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Beneficial Owner: Shares Registered in the Name of a Broker or Bank<font style="font-style:normal;">.&nbsp;&nbsp;If on the record date your shares or units were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that organization.&nbsp;&nbsp;As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account.&nbsp;&nbsp;You are also invited to attend the special meeting virtually.&nbsp;&nbsp;However, since you are not the stockholder of record, you may not vote your shares virtually at the special meeting unless you request and obtain a valid proxy from your broker or other agent.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What interests do the Company&#8217;s directors and executive officers have in the approval of the Extension Amendment Proposal?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s directors and executive officers have interests in the Extension Amendment Proposal that may be different from, or in addition to, your interests as a stockholder.&nbsp;&nbsp;These interests include ownership by them or their affiliates of founder shares, and warrants that may become exercisable in the future, loans by them that will not be repaid in the event of our winding up and the possibility of future compensatory arrangements.&nbsp;&nbsp;See the section&#160;entitled &#8220;<font style="font-style:italic;">The Extension Amendment &#8212; Interests of the Company&#8217;s Directors and Officers</font>.&#8221;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What if I object to the Extension Amendment Proposal and/or the Adjournment Proposal?&nbsp;&nbsp;Do I have appraisal rights?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders do not have appraisal rights in connection with either the Extension Amendment Proposal or, if presented, the Adjournment Proposal under the DGCL.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What happens to the Company&#8217;s warrants if the Extension Amendment Proposal is not approved?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company has not consummated an initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest income earned on the trust account (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no distribution from the trust account with respect to our warrants, which will expire worthless in the event the Company winds up.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What happens to the Company warrants if the Extension Amendment Proposal is approved?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, the Company will continue its efforts to consummate a business combination until the Extended Date and will retain the blank check company restrictions previously applicable to it.&nbsp;&nbsp;The warrants will remain outstanding in accordance with their terms.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How are the funds in the trust account currently being held?</p> <div></div>
<p style="text-align:justify;margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to the regulation of special purpose acquisition companies like the Company (&#8220;<font style="font-weight:bold;font-style:italic;">SPACs</font>&#8221;), on March 30, 2022, the SEC issued proposed rules (the &#8220;<font style="font-weight:bold;font-style:italic;">SPAC Rule Proposals</font>&#8221;) relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the condensed financial statement requirements applicable to transactions involving shell companies; the use of projections by SPACs in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940, as amended, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC&#8217;s duration, asset composition, business purpose and activities.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With regard to the SEC&#8217;s investment company proposals included in the SPAC Rule Proposals, while the funds in the trust account have, since the Company&#8217;s initial public offering, been held only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, to mitigate the risk of being viewed as operating an unregistered investment company (including pursuant to the subjective test of Section 3(a)(1)(A) of the Investment Company Act of 1940), on June 22, 2022, the Company instructed Continental Stock Transfer &amp; Trust Company, the trustee managing the trust account, to hold all funds in the trust account in cash until the earlier of consummation of the business combination and liquidation of the Company.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">How do I redeem my public shares?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension is implemented, each public stockholder may seek to redeem all or a portion of his or her public shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the approval of the Extension, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares.&nbsp;&nbsp;You will also be able to redeem your public shares in connection with any stockholder vote to approve a business combination, or if the Company has not consummated a business combination by the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to our charter, a public stockholder may request that the Company redeem all or a portion of such public stockholder&#8217;s public shares for cash if the Extension Amendment Proposal is approved.&nbsp;&nbsp;You will be entitled to receive cash for any public shares to be redeemed only if you:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">(a) hold public shares or (b) hold public shares through units and you elect to separate your units into the underlying public shares and public warrants prior to exercising your redemption rights with respect to the public shares; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">prior to 5:00 p.m. Eastern Time, on July 21, 2022 (two business days prior to the scheduled vote at the special meeting), (a) submit a written request, including the name, phone number, and address of the beneficial owner of the shares for which redemption is requested, to Continental Stock Transfer &amp; Trust Company, the Company&#8217;s transfer agent, at Continental Stock Transfer &amp; Trust Company, 1 State Street, 30th Floor, New York, New York 10004, Attn: Mark Zimkind, that the Company redeem your public shares for cash and (b)&#160;deliver your public shares to the transfer agent, physically or electronically through The Depository Trust Company (&#8220;<font style="font-weight:bold;font-style:italic;">DTC</font>&#8221;).</p></td></tr></table></div> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Holders of units must elect to separate the underlying public shares and public warrants prior to exercising redemption rights with respect to the public shares.&nbsp;&nbsp;If holders hold their units in an account at a brokerage firm or bank, holders must notify their broker or bank that they elect to separate the units into the underlying public shares and public warrants, or if a holder holds units registered in its own name, the holder must contact the transfer agent directly and instruct it to do so.&nbsp;&nbsp;<font style="font-weight:bold;">Public stockholders may elect to redeem all or a portion of their public shares regardless of whether they vote for or against the Extension Amendment Proposal and regardless of whether they hold public shares on the record date.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you hold your shares through a bank or broker, you must ensure your bank or broker complies with the requirements identified herein, including submitting a written request that your shares be redeemed for cash to the transfer agent and delivering your shares to the transfer agent prior to 5:00 p.m. Eastern Time on July 21, 2022 (two </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">business days before the scheduled vote at the special meeting)</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Y</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ou will only be entitled to receive cash in connection with a redemption of these shares if you continue to hold them until the effective date of the Extension Amendment and Election.</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through DTC&#8217;s DWAC (Deposit/Withdrawal at Custodian) System, this electronic delivery process can be accomplished by the stockholder, whether or not it is a record holder or its shares are held in &#8220;street name,&#8221; by contacting the transfer agent or its broker and requesting delivery of its shares through the DWAC system.&nbsp;&nbsp;Delivering shares physically may take significantly longer.&nbsp;&nbsp;In order to obtain a physical stock certificate, a stockholder&#8217;s broker and/or clearing broker, DTC, and the Company&#8217;s transfer agent will need to act together to facilitate this request.&nbsp;&nbsp;There is a nominal cost associated with the above&#8209;referenced tendering process and the act of certificating the shares or delivering them through the DWAC system.&nbsp;&nbsp;The transfer agent will typically charge the tendering broker $100 and the broker would determine whether or not to pass this cost on to the redeeming holder.&nbsp;&nbsp;It is the Company&#8217;s understanding that stockholders should generally allot at least two weeks to obtain physical certificates from the transfer agent.&nbsp;&nbsp;The Company does not have any control over this process or over the brokers or DTC, and it may take longer than two weeks to obtain a physical stock certificate.&nbsp;&nbsp;Such stockholders will have less time to make their investment decision than those stockholders that deliver their shares through the DWAC system.&nbsp;&nbsp;Stockholders who request physical stock certificates and wish to redeem may be unable to meet the deadline for tendering their shares before exercising their redemption rights and thus will be unable to redeem their shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates that have not been tendered in accordance with these procedures prior to the vote on the Extension Amendment Proposal will not be redeemed for cash held in the trust account.&nbsp;&nbsp;In the event that a public stockholder tenders its shares and decides prior to the vote at the special meeting that it does not want to redeem its shares, the stockholder may withdraw the tender.&nbsp;&nbsp;If you delivered your shares for redemption to our transfer agent and decide prior to the vote at the special meeting not to redeem your public shares, you may request that our transfer agent return the shares (physically or electronically).&nbsp;&nbsp;You may make such request by contacting our transfer agent at the address listed above.&nbsp;&nbsp;In the event that a public stockholder tenders shares and the Extension Amendment Proposal is not approved, these shares will not be redeemed and the physical certificates representing these shares will be returned to the stockholder promptly following the determination that the Extension Amendment Proposal will not be approved.&nbsp;&nbsp;The Company anticipates that a public stockholder who tenders shares for redemption in connection with the vote to approve the Extension would receive payment of the redemption price for such shares soon after the completion of the Extension Amendment.&nbsp;&nbsp;The transfer agent will hold the certificates of public stockholders that make the election until such shares are redeemed for cash or returned to such stockholders.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If I am a unit holder, can I exercise redemption rights with respect to my units?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No.  Holders of outstanding units must separate the underlying public shares and public warrants (as defined below) prior to exercising redemption rights with respect to the public shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you hold units registered in your own name, you must deliver the certificate for such units to Continental Stock Transfer &amp; Trust Company, our transfer agent, with written instructions to separate such units into public shares, and public warrants.&nbsp;&nbsp;This must be completed far enough in advance to permit the mailing of the public share certificates back to you so that you may then exercise your redemption rights upon the separation of the public shares from the units.&nbsp;&nbsp;See &#8220;<font style="font-style:italic;">How do I redeem my public shares</font>?&#8221; above.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">What should I do if I receive more than one set of voting materials?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may receive more than one set of voting materials, including multiple copies of this proxy statement and multiple proxy cards or voting instruction cards, if your shares are registered in more than one name or are registered in different accounts.&nbsp;&nbsp;For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares.&nbsp;&nbsp;Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast a vote with respect to all of your shares of common stock.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Who is paying for this proxy solicitation?</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will pay for the entire cost of soliciting proxies.&nbsp;&nbsp;The Company has engaged Morrow Sodali LLC (&#8220;<font style="font-weight:bold;font-style:italic;">Morrow Sodali</font>&#8221;) to assist in the solicitation of proxies for the special meeting.&nbsp;&nbsp;The Company has agreed to pay Morrow Sodali a fee of $32,500.&nbsp;&nbsp;The Company will also reimburse Morrow Sodali for reasonable and customary out&#8209;of&#8209;pocket expenses.&nbsp;&nbsp;In addition to these mailed proxy materials, our directors and executive officers may also solicit proxies in person, by telephone or by other means of communication.&nbsp;&nbsp;These parties will not be paid any additional compensation for soliciting proxies.&nbsp;&nbsp;The Company may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Where do I find the voting results of the special meeting?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will announce preliminary voting results at the special meeting.&nbsp;&nbsp;The final voting results will be tallied by the inspector of election and published in the Company&#8217;s Current Report on Form 8&#8209;K, which the Company is required to file with the SEC within four business days following the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Who can help answer my questions?</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you have questions about the proposals or if you need additional copies of the proxy statement or the enclosed proxy card you should contact:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-align:center;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">East Resources Acquisition Company<br />7777 NW Beacon Square Boulevard</p>
<p style="margin-top:0pt;text-align:center;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Boca Raton, Florida 33487<br />Attn: Kelly Seward<br />Email: info@eastresources.com </p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may also contact the Company&#8217;s proxy solicitor at:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Morrow Sodali LLC<br />333 Ludlow Street, 5th Floor, South Tower<br />Stamford, CT 06902<br />Tel: (800) 662&#8209;5200 (toll&#8209;free) or<br />(203) 658&#8209;9400 (banks and brokers can call collect)<br />Email: ERES.info@investor.morrowsodali.com</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may also obtain additional information about the Company from documents filed with the SEC by following the instructions in the section&#160;entitled &#8220;<font style="font-style:italic;">Where You Can Find More Information</font>.&#8221;</p><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="SPECIAL_MEETING"></a><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="SPECIAL_MEETING"></a>THE SPECIA</font><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">L MEETING</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431832"></a><a name="DATE_TIME_PLACE_PURPOSE__SPECIAL_MEETING"></a><a name="DATE_TIME_PLACE_PURPOSE__SPECIAL_MEETING"></a>Date, Time, Place and Purpose of the Special Meeting</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The special meeting will be held at 10:00 a.m. Eastern Time, on July 25, 2022.&nbsp;&nbsp;The special meeting will be held virtually, at https://www.cstproxy.com/eastresources/2022.&nbsp;&nbsp;At the special meeting, the stockholders will consider and vote upon the following proposals.</p> <div></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;">The Extension Amendment Proposal:</font> To amend our charter to extend the date by which the Company must consummate a business combination from July&#160;27, 2022 (the date that is 24&#160;months from the closing date of the IPO), to January 27, 2023 (the date that is 30 months from the closing date of the IPO).</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;">The Adjournment Proposal:</font> A proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension.</p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431833"></a><a name="VOTING_POWER_RECORD_DATE"></a><a name="VOTING_POWER_RECORD_DATE"></a>Voting Power; Record Date</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You will be entitled to vote or direct votes to be cast at the special meeting if you owned our common stock, including as a constituent part of a unit, at the close of business on June 27, 2022, the record date for the special meeting.&nbsp;&nbsp;You will have one vote per share for each share of common stock you owned at that time.&nbsp;&nbsp;Our warrants do not carry voting rights.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the close of business on the record date, there were 43,125,000 outstanding shares of common stock, each of which entitles its holder to cast one vote per share.&nbsp;&nbsp;The warrants do not carry voting rights.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431834"></a><a name="VOTES_REQUIRED"></a><a name="VOTES_REQUIRED"></a>Votes Required</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Extension Amendment Proposal will require the affirmative vote of holders of 65% of the Company&#8217;s Class A common stock and Class B common stock, voting together as a single class, outstanding on the record date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the Adjournment Proposal requires the affirmative vote of the majority of the votes cast by stockholders represented in person (including virtually) or by proxy at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not vote (i.e., you &#8220;abstain&#8221; from voting), your action will have the same effect as an &#8220;AGAINST&#8221; vote with regards to the Extension Amendment Proposal.&nbsp;&nbsp;Abstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the outcome of the Adjournment Proposal.&nbsp;&nbsp;Broker non&#8209;votes will have the same effect as &#8220;AGAINST&#8221; votes with respect to the Extension Amendment Proposal; however, since the Adjournment Proposal is considered a routine matter, brokers shall be entitled to vote on the Adjournment Proposal absent voting instructions, and thus there should be no broker non&#8209;votes with respect to the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not want the Extension Amendment Proposal to be approved, you must abstain, not vote, or vote against the proposal.&nbsp;&nbsp;The Company anticipates that a public stockholder who tenders shares for redemption in connection with the vote to approve the Extension Amendment Proposal would receive payment of the redemption price for such shares soon after the completion of the Extension Amendment.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not want the Adjournment Proposal to be approved, you must vote against the proposal.&nbsp;&nbsp;Abstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the outcome of the Adjournment Proposal.&nbsp;&nbsp;Since the Adjournment Proposal is considered a routine matter, brokers shall be entitled to vote on the Adjournment Proposal absent voting instructions, and thus there should be no broker non&#8209;votes with respect to the Adjournment Proposal.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431835"></a><a name="VOTING"></a><a name="VOTING"></a>Voting</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You can vote your shares at the special meeting by proxy or virtually.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You can vote by proxy by having one or more individuals who will be at the special meeting vote your shares for you.&nbsp;&nbsp;These individuals are called &#8220;proxies&#8221; and using them to cast your vote at the special meeting is called voting &#8220;by proxy.&#8221;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you wish to vote by proxy, you must (i) complete the enclosed form, called a &#8220;proxy card,&#8221; and mail it in the envelope provided or (ii) submit your proxy by telephone or over the Internet (if those options are available to you) in accordance with the instructions on the enclosed proxy card or voting instruction card.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you complete the proxy card and mail it in the envelope provided or submit your proxy by telephone or over the Internet as described above, you will designate Gary Hagerman and John Sieminski to act as your proxy at the special meeting.&nbsp;&nbsp;One of them will then vote your shares at the special meeting in accordance with the instructions you have given them in the proxy card or voting instructions, as applicable, with respect to the proposals presented in this proxy statement.&nbsp;&nbsp;Proxies will extend to, and be voted at, any adjournment(s) of the special meeting.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alternatively, you can vote your shares in person by attending the special meeting virtually.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">A special note for those who plan to attend the special meeting and vote virtually: if your shares or units are held in the name of a broker, bank or other nominee, please follow the instructions you receive from your broker, bank or other nominee holding your shares.&nbsp;&nbsp;You will not be able to vote at the special meeting unless you obtain a legal proxy from the record holder of your shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Board is asking for your proxy.&nbsp;&nbsp;Giving our Board your proxy means you authorize it to vote your shares at the special meeting in the manner you direct.&nbsp;&nbsp;You may vote for or against any proposal or you may abstain from voting.&nbsp;&nbsp;All valid proxies received prior to the special meeting will be voted.&nbsp;&nbsp;All shares represented by a proxy will be voted, and where a stockholder specifies by means of the proxy a choice with respect to any matter to be acted upon, the shares will be voted in accordance with the specification so made.&nbsp;&nbsp;If no choice is indicated on the proxy, the shares will be voted &#8220;FOR&#8221; both the Extension Amendment Proposal and, if presented, the Adjournment Proposal, and as the proxy holders may determine in their discretion with respect to any other matters that may properly come before the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders who have questions or need assistance in completing or submitting their proxy cards should contact our proxy solicitor, Morrow Sodali, at (203) 658&#8209;9400 (call collect), (800) 662&#8209;5200 (call toll&#8209;free), or by sending an email to ERES.info@investor.morrowsodali.com .</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders who hold their shares in &#8220;street name,&#8221; meaning the name of a broker or other nominee who is the record holder, must either direct the record holder of their shares to vote their shares or obtain a legal proxy from the record holder to vote their shares at the special meeting.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431836"></a><a name="REVOCABILITY_PROXIES"></a><a name="REVOCABILITY_PROXIES"></a>Revocability of Proxies</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any proxy may be revoked by the person giving it at any time before the polls close at the special meeting.&nbsp;&nbsp;A proxy may be revoked by filing with John Sieminski, at East Resources Acquisition Company, 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487, either a written notice of revocation bearing a date later than the date of such proxy or a subsequent proxy relating to the same shares or by attending the special meeting and voting virtually.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Simply attending the special meeting will not constitute a revocation of your proxy.&nbsp;&nbsp;If your shares are held in the name of a broker or other nominee who is the record holder, you must follow the instructions of your broker or other nominee to revoke a previously given proxy.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431837"></a><a name="ATTENDANCE_AT_SPECIAL_MEETING"></a><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ATTENDANCE_AT_SPECIAL_MEETING"></a>Attendance at the</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> Special Meeting</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Only holders of common stock, their proxy holders and guests the Company may invite may attend the special meeting.&nbsp;&nbsp;If you wish to attend the special meeting virtually but you hold your shares or units through someone else, such as a broker, please follow the instructions you receive from your broker, bank or other nominee holding your shares.&nbsp;&nbsp;You must bring a legal proxy from the broker, bank or other nominee holding your shares, confirming your beneficial ownership of the shares and giving you the right to vote your shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431838"></a><a name="SOLICITATION_PROXIES"></a><a name="SOLICITATION_PROXIES"></a>Solicitation of Proxies</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your proxy is being solicited by our Board on the proposals being presented to the stockholders at the special meeting.&nbsp;&nbsp;The Company has agreed to pay Morrow Sodali a fee of $32,500.&nbsp;&nbsp;The Company will also reimburse Morrow Sodali for reasonable and customary out&#8209;of&#8209;pocket expenses.&nbsp;&nbsp;In addition to these mailed proxy materials, our directors and executive officers may also solicit proxies in person, by telephone or by other means of communication.&nbsp;&nbsp;These parties will not be paid any additional compensation for soliciting proxies.&nbsp;&nbsp;The Company may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.&nbsp;&nbsp;You may contact Morrow Sodali at:</p> <div></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Morrow Sodali LLC<br />333 Ludlow Street, 5th Floor, South Tower<br />Stamford, CT 06902<br />Tel: (800) 662&#8209;5200 (toll&#8209;free) or<br />(203) 658&#8209;9400 (banks and brokers can call collect)<br />Email: ERES.info@investor.morrowsodali.com </p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cost of preparing, assembling, printing and mailing this proxy statement and the accompanying form of proxy, and the cost of soliciting proxies relating to the special meeting, will be borne by the Company.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some banks and brokers have customers who beneficially own common stock listed of record in the names of nominees.&nbsp;&nbsp;The Company intends to request banks and brokers to solicit such customers and will reimburse them for their reasonable out-of-pocket expenses for such solicitations.&nbsp;&nbsp;If any additional solicitation of the holders of our outstanding common stock is deemed necessary, the Company (through our directors and executive officers) anticipates making such solicitation directly.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431839"></a><a name="NO_RIGHT_APPRAISAL"></a><a name="NO_RIGHT_APPRAISAL"></a>No Right of Appraisal</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s stockholders do not have appraisal rights under the DGCL in connection with the proposals to be voted on at the special meeting.&nbsp;&nbsp;Accordingly, our stockholders have no right to dissent and obtain payment for their shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431840"></a><a name="OR_BUSINESS"></a><a name="OR_BUSINESS"></a>Other Business</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is not currently aware of any business to be acted upon at the special meeting other than the matters discussed in this proxy statement.&nbsp;&nbsp;The form of proxy accompanying this proxy statement confers discretionary authority upon the named proxy holders with respect to amendments or variations to the matters identified in the accompanying Notice of Special Meeting and with respect to any other matters which may properly come before the special meeting.&nbsp;&nbsp;If other matters do properly come before the special meeting, or at any adjournment(s) of the special meeting, the Company expects that the shares of common stock represented by properly submitted proxies will be voted by the proxy holders in accordance with the recommendations of our Board.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431841"></a><a name="PRINCIPAL_EXECUTIVE_FICES"></a><a name="PRINCIPAL_EXECUTIVE_FICES"></a>Principal Executive Offices</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our principal executive offices are located 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487.&nbsp;&nbsp;Our telephone number at such address is (561) 826-3620.</p><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="EXTENSION_AMENDMENT_PROPOSAL"></a><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="EXTENSION_AMENDMENT_PROPOSAL"></a>THE EXTENSION AM</font><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">ENDMENT PROPOSAL</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431843"></a><a name="BACKGROUND"></a><a name="BACKGROUND"></a>Background</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase reorganization or similar business combination with one or more businesses.&nbsp;&nbsp;We were incorporated in Delaware on May 22, 2020.&nbsp;&nbsp;In connection with our formation, we issued an aggregate of 8,625,000 founder shares to our Sponsor for an aggregate purchase price of $25,000.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 27, 2020, we consummated our IPO of 30,000,000 units.  On August 25, 2020, we consummated the full exercise of the underwriters&#8217; 4,500,000 unit over-allotment option.  Each unit consists of one share of Class&#160;A common stock and one&#8209;half of one redeemable public warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock for $11.50 per share.&nbsp;&nbsp;The units were sold at a price of $10.00 per unit, generating gross proceeds of $345,000,000.  Simultaneously with the consummation of the IPO, we completed the private sale of an aggregate of 8,000,000 private placement warrants to our Sponsor at a price of $1.00 per warrant, generating gross proceeds of $8,000,000.  Simultaneously with the consummation of the full exercise of the underwriters&#8217; over-allotment option, we completed the private sale of an additional 900,000 private placement warrants to our Sponsor at a price of $1.00 per warrant, generating additional gross proceeds of $900,000.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A total of $345,000,000 of the net proceeds from our initial public offering (including the over-allotment) and the private placement with the Sponsor were deposited in a trust account established for the benefit of the Company&#8217;s public stockholders.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431844"></a><a name="EXTENSION_AMENDMENT"></a><a name="EXTENSION_AMENDMENT"></a>The Extension Amendment</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is proposing to amend its charter to extend the date by which the Company must consummate a business combination to the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sole purpose of the Extension Amendment Proposal is to provide the Company with sufficient time to complete an initial business combination.&nbsp;&nbsp;Approval of the Extension Amendment Proposal is a condition to the implementation of the Extension.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are currently in active negotiations with respect to a business combination.&nbsp;&nbsp;In the event that we enter into a definitive agreement for an initial business combination prior to the special meeting, we will issue a press release and file a Current Report on Form 8&#8209;K with the SEC announcing a proposed business combination.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company has not consummated an initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to complete an initial business combination within the Combination Period.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A copy of the proposed amendment to the Company&#8217;s charter is attached to this proxy statement as <font style="text-decoration:underline;">Annex&#160;A</font>.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431845"></a><a name="REASONS_FOR_PROPOSAL"></a><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="REASONS_FOR_PROPOSAL"></a>Reasons for t</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">he Proposal</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s IPO prospectus and charter provide that the Company has until the last day of the Combination Period to complete a business combination.&nbsp;&nbsp;The sole purpose of the Extension Amendment Proposal is to provide the Company with sufficient time to complete a business combination, which our Board believes is in the best interest of our stockholders.&nbsp;&nbsp;The Company believes that given the Company&#8217;s expenditure of time, effort and money on searching for potential business combination opportunities, including the fact that we are in active discussions regarding a business combination, circumstances warrant providing public stockholders an opportunity to consider an initial business combination.&nbsp;&nbsp;Accordingly, since the Company will not be able to complete an initial business combination within the Combination Period, the Company has determined to seek stockholder approval to extend the time for closing a business combination beyond the last day of the Combination Period to the Extended Date.&nbsp;&nbsp;The Company and its officers and directors agreed that they would not seek to amend the Company&#8217;s charter to allow for a longer period of time to complete a business combination unless the Company provided holders of public shares with the right to seek conversion of their public shares in connection therewith.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431846"></a><a name="IF_EXTENSION_AMENDMENT_PROPOSAL_IS_NOT_A"></a><a name="IF_EXTENSION_AMENDMENT_PROPOSAL_IS_NOT_A"></a>If the Extension Amendment Proposal is Not Approved</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholder approval of the Extension Amendment Proposal is required for the implementation of our Board&#8217;s plan to extend the date by which we must consummate an initial business combination.&nbsp;&nbsp;Therefore, our Board will abandon and not implement the Extension Amendment unless our stockholders approve the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is not approved and the Company does not consummate an initial business combination within the Combination Period, as contemplated by our IPO prospectus and in accordance with our charter, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&nbsp;&nbsp;There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless in the event the Company winds up.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The holders of the founder shares have waived their rights to participate in any liquidation distribution with respect to such shares.&nbsp;&nbsp;There will be no distribution from the trust account with respect to the Company&#8217;s warrants, which will expire worthless in the event the Extension Amendment Proposal is not approved.&nbsp;&nbsp;The Company will pay the costs of liquidation from its remaining assets outside of the trust account.&nbsp;&nbsp;If such funds are insufficient, our Sponsor has agreed to advance it the funds necessary to complete such liquidation and has agreed not to seek repayment of such expenses.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431847"></a><a name="IF_EXTENSION_AMENDMENT_PROPOSAL_IS_APPRO"></a><a name="IF_EXTENSION_AMENDMENT_PROPOSAL_IS_APPRO"></a>If the Extension Amendment Proposal is Approved</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, the Company will file an amendment to the charter with the Secretary of State of the State of Delaware in the form of <font style="text-decoration:underline;">Annex A</font> hereto to extend the time it has to complete a business combination until the Extended Date.&nbsp;&nbsp;The Company will remain a reporting company under the Exchange Act, and its units, common stock and public warrants will remain publicly traded.&nbsp;&nbsp;The Company will then continue to work to consummate a business combination by the Extended Date.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">You are not being asked to vote on a business combination at this time</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">f the Extension is implemented and you do not elect to redeem your public shares in connection with the Extension, you will retain the right to vote on a business combination when it is submitted to the public stockholders (provided that you are a stockholder on the record date for a meeting to consider a business combination) and the right to redeem your public shares for a pro rata portion of the trust account in the event a business combination is approved and completed or the Company has not consummated a business combination by the Extended Date.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved and the Extension is implemented, the removal of the Withdrawal Amount from the trust account in connection with the Election will reduce the amount held in the trust account following the Election.&nbsp;&nbsp;The Company cannot predict the amount that will remain in the trust account after such withdrawal if the Extension Amendment Proposal is approved and the amount remaining in the trust account may be only a fraction of the $345,433,069.01 (including interest but less the funds used to pay taxes) that was in the trust account as of the record date.&nbsp;&nbsp;In such event, the Company may still seek to obtain additional funds to complete a business combination, and there can be no assurance that such funds will be available on terms acceptable to the parties or at all.&nbsp;&nbsp;We will not proceed with the Extension if redemptions or repurchases of our public shares cause us to have less than $5,000,001 of net tangible assets following approval of the Extension Amendment Proposal.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431848"></a><a name="REDEMPTION_RIGHTS"></a><a name="REDEMPTION_RIGHTS"></a>Redemption Rights</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Extension Amendment Proposal is approved, and the Extension is implemented, public stockholders may elect to redeem their shares for a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to such approval, including any interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares.&nbsp;&nbsp;However, the Company may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001.&nbsp;&nbsp;If the Extension Amendment Proposal is approved by the requisite vote of stockholders, the remaining holders of public shares will retain the opportunity to have their public shares redeemed in conjunction with the consummation of a business combination, subject to any limitations set forth in our charter, as amended.&nbsp;&nbsp;In addition, public stockholders who vote for the Extension Amendment Proposal and do not make the Election would be entitled to have their shares redeemed for cash if the Company has not completed a business combination by the Extended Date.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk107609211"></a>If the Extension Amendment Proposal is approved, our Sponsor, or its designee, has agreed to advance to us as a loan (i) $0.033 for each public share that is not redeemed in connection with the special meeting plus (ii) $0.033 for each public share that is not redeemed for each subsequent calendar month commencing on August 27, 2022, and on the 27th day of each subsequent month, or portion thereof, that we require to complete a business combination from January 27, 2023 until the Extended Date. For example, if we complete the business combination on October 27, 2022, which would represent six calendar months, our Sponsor or its designee would make aggregate maximum advances of approximately $0.198<a name="_Hlk107609211"></a> per share (assuming no public shares were redeemed). Assuming the Extension Amendment Proposal is approved, the initial contribution will be deposited in the trust account promptly following the special meeting. Each additional contribution will be deposited in the trust account on or before the 27th day of such calendar month.&nbsp;&nbsp;Accordingly, if the Extension Amendment Proposal is approved and the Extension is implemented and we take the full time through the Extended Date to complete a business combination, the redemption amount per share at the meeting for such business combination or the Company&#8217;s subsequent liquidation will be approximately $10.199 per share, in comparison to the current redemption amount of $10.01 per share. The advances are conditioned upon the implementation of the Extension Amendment Proposal and will not occur if the Extension Amendment Proposal is not approved or the Extension is not completed. The amount of the advances will not bear interest and will be repayable by the Company to our Sponsor or its designees upon consummation of the business combination.&nbsp;&nbsp;At the option of the Sponsor, up to $1,500,000 of the loan may be converted into warrants identical to the warrants sold in the private placement that was consummated simultaneously with our IPO, at $1.50 per warrant.  If our Sponsor or its designee advises the Company that it does not intend to make the advances, then the Extension Amendment Proposal and the Adjournment Proposal will not be put before the shareholders at the special meeting and we will dissolve and liquidate in accordance with our charter.&nbsp;&nbsp;Our Sponsor or its designees will have the sole discretion whether to continue extending for additional calendar months </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">until the Extended Date and if our Sponsor determines not to continue extending for additional calendar months, its obligation to make additional </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">advances</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will terminate.</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST ENSURE YOUR BANK OR BROKER COMPLIES WITH THE REQUIREMENTS IDENTIFIED HEREIN, INCLUDING SUBMITTING A WRITTEN REQUEST THAT YOUR SHARES BE REDEEMED FOR CASH TO THE TRANSFER AGENT AND DELIVERING YOUR SHARES TO THE TRANSFER AGENT PRIOR TO 5:00&#160;P.M. EST ON JULY 21, 2022 (TWO BUSINESS DAYS BEFORE THE SCHEDULED VOTE AT THE SPECIAL MEETING).&nbsp;&nbsp;YOU WILL ONLY BE ENTITLED TO RECEIVE CASH IN CONNECTION WITH A REDEMPTION OF THESE SHARES IF YOU CONTINUE TO HOLD THEM UNTIL THE EFFECTIVE DATE OF THE EXTENSION AMENDMENT PROPOSAL AND ELECTION.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to our charter, a public stockholder may request that the Company redeem all or a portion of such public stockholder&#8217;s public shares for cash if the Extension Amendment Proposal is approved.&nbsp;&nbsp;You will be entitled to receive cash for any public shares to be redeemed only if you:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">(a) hold public shares or (b) hold public shares through units and you elect to separate your units into the underlying public shares and public warrants prior to exercising your redemption rights with respect to the public shares; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">prior to 5:00 p.m. Eastern Time, on July 21, 2022 (two business days prior to the scheduled vote at the special meeting), (a) submit a written request, including the name, phone number, and address of the beneficial owner of the shares for which redemption is requested, to Continental Stock Transfer &amp; Trust Company, the Company&#8217;s transfer agent, at Continental Stock Transfer &amp; Trust Company, 1 State Street, 30th Floor, New York, New York 10004, Attn: Mark Zimkind, that the Company redeem your public shares for cash and (b)&#160;deliver your public shares to the transfer agent, physically or electronically through DTC.</p></td></tr></table></div> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Holders of units must elect to separate the underlying public shares and public warrants prior to exercising redemption rights with respect to the public shares.&nbsp;&nbsp;If holders hold their units in an account at a brokerage firm or bank, holders must notify their broker or bank that they elect to separate the units into the underlying public shares and public warrants, or if a holder holds units registered in its own name, the holder must contact the transfer agent directly and instruct it to do so.&nbsp;&nbsp;<font style="font-weight:bold;">Public stockholders may elect to redeem all or a portion of their public shares regardless of whether they vote for or against the Extension Amendment Proposal and regardless of whether they hold public shares on the record date.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through DTC&#8217;s DWAC (Deposit/Withdrawal at Custodian) System, this electronic delivery process can be accomplished by the stockholder, whether or not it is a record holder or its shares are held in &#8220;street name,&#8221; by contacting the transfer agent or its broker and requesting delivery of its shares through the DWAC system.&nbsp;&nbsp;Delivering shares physically may take significantly longer.&nbsp;&nbsp;In order to obtain a physical stock certificate, a stockholder&#8217;s broker and/or clearing broker, DTC, and the Company&#8217;s transfer agent will need to act together to facilitate this request.&nbsp;&nbsp;There is a nominal cost associated with the above&#8209;referenced tendering process and the act of certificating the shares or delivering them through the DWAC system.&nbsp;&nbsp;The transfer agent will typically charge the tendering broker $100 and the broker would determine whether or not to pass this cost on to the redeeming holder.&nbsp;&nbsp;It is the Company&#8217;s understanding that stockholders should generally allot at least two weeks to obtain physical certificates from the transfer agent.&nbsp;&nbsp;The Company does not have any control over this process or over the brokers or DTC, and it may take longer than two weeks to obtain a physical stock certificate.&nbsp;&nbsp;Such stockholders will have less time to make their investment decision than those stockholders that deliver their shares through the DWAC system.&nbsp;&nbsp;Stockholders who request physical stock certificates and wish to redeem may be unable to meet the deadline for tendering their shares before exercising their redemption rights and thus will be unable to redeem their shares.&nbsp;&nbsp;Certificates that have not been tendered in accordance with these procedures prior to the vote on the Extension Amendment will not be redeemed for cash held in the trust account on the redemption date.&nbsp;&nbsp;In the event that a public stockholder tenders its shares and decides prior to the vote at the special meeting that it does not want to redeem its shares, the stockholder may withdraw the tender.&nbsp;&nbsp;If you delivered your shares for redemption to our transfer agent and decide prior to the vote at the special meeting not to redeem your public shares, you may request that our transfer agent return the shares (physically or electronically).&nbsp;&nbsp;You may make such request by contacting our transfer agent at the address listed above.&nbsp;&nbsp;In the event that a public stockholder tenders shares and the Extension </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment Proposal is not approved, these shares will not be redeemed and the physical certificates representing these shares will be returned to the stockholder promptly following the determination that the Extension Amendment will not be approved</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;T</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he Company anticipates that a public stockholder who tenders shares for redemption in connection with the vote to approve the Extension would receive payment of the redemption price for such shares soon after the completion of the Extension Amendment</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;T</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he transfer agent will hold the certificates of public stockholders that make the election until such shares are redeemed for cash or returned to such stockholders.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If properly demanded, the Company will redeem each public share for a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding public shares.&nbsp;&nbsp;Based on the amount in the trust account as of the record date, this would amount to approximately $10.01 per share.&nbsp;&nbsp;The closing price of the public shares on NASDAQ on June 27, 2022, the record date, was $9.98.&nbsp;&nbsp;Accordingly, if the market price were to remain the same until the date of the special meeting, exercising redemption rights would result in a public stockholder receiving approximately $0.03 more than if such stockholder sold the public shares in the open market.&nbsp;&nbsp;The Company cannot assure public stockholders that they will be able to sell their public shares in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such stockholders wish to sell their shares.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you exercise your redemption rights, you will be exchanging your shares of the Company&#8217;s common stock for cash and will no longer own the shares.&nbsp;&nbsp;You will be entitled to receive cash for these shares only if you properly demand redemption and tender your stock certificate(s) to the Company&#8217;s transfer agent prior to 5:00 p.m. Eastern Time on July 21, 2022 (two business days before the scheduled vote at the special meeting).&nbsp;&nbsp;The Company anticipates that a public stockholder who tenders shares for redemption in connection with the vote to approve the Extension Amendment would receive payment of the redemption price for such shares soon after the completion of the Extension Amendment.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431849"></a><a name="INTERESTS__COMPANYS_DIRECTORS_EXECUTIVE_"></a>Interests of the Company&#8217;<a name="INTERESTS__COMPANYS_DIRECTORS_EXECUTIVE_"></a>s Directors and Executive Officers</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When you consider the recommendation of our Board, you should keep in mind that the Company&#8217;s executive officers and directors, and their affiliates, have interests that may be different from, or in addition to, your interests as a stockholder.&nbsp;&nbsp;These interests include, among other things:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">If the Extension Amendment Proposal is not approved and the Company does not consummate an initial business combination within the Combination Period, in accordance with our charter, the 8,625,000 founder shares, which were acquired by our Sponsor directly from the Company for an aggregate investment of $25,000, or approximately $0.003 per share, will be worthless (as the initial stockholders have waived liquidation rights with respect to such shares).&nbsp;&nbsp;The founder shares had an aggregate market value of approximately $86,077,500 based on the last sale price of $9.98 on NASDAQ on June 27, 2022 (the record date);</font></p></td></tr></table></div> <div></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">If the Extension Amendment Proposal is not approved and the Company does not consummate an initial business combination within the Combination Period, in accordance with our charter, the 8,900,000 private placement warrants purchased by our Sponsor for an aggregate investment of $8,900,000, or $1.00 per warrant, will be worthless, as they will expire.&nbsp;&nbsp;The private placement warrants had an aggregate market value of $1,958,000 based on the last sale price of $0.22 on the NASDAQ on June 27, 2022 (the record date);</font></p></td></tr></table></div> <div></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Even if the trading price of the Class A common stock were as low as $0.003 per share, the aggregate market value of the founder shares alone (without taking into account the value of the private placement warrants) would be approximately equal to the initial investment in the Company by our Sponsor.&nbsp;&nbsp;As a result, if an initial business combination is completed, the initial stockholders are likely to be able to make a substantial profit on their investment in us even at a time when the Class A common stock has lost significant value.&nbsp;&nbsp;On the other hand, if the Extension Amendment Proposal is not approved and the Company liquidates without completing its initial business combination before July&#160;27, 2022, the initial stockholders will lose their entire investment in us.</font></p></td></tr></table></div> <div></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Our Sponsor has agreed that it will be liable to us, if and to the extent any claims by a vendor for services rendered or products sold to us, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below: (i) $10.00 per public share; or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case, net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">All rights specified in the charter relating to the right of officers and directors to be indemnified by the Company, and of the Company&#8217;s executive officers and directors to be exculpated from monetary liability with respect to prior acts or omissions, will continue after a business combination.&nbsp;&nbsp;If a business combination is not approved and the Company liquidates, the Company will not be able to perform its obligations to its officers and directors under those provisions;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">All of the current members of our Board are expected to continue to serve as directors at least through the date of the special meeting to approve a business combination and some are expected to continue to serve following a business combination as discussed above and receive compensation thereafter; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">The Company&#8217;s executive officers and directors, and their affiliates are entitled to reimbursement of out&#8209;of&#8209;pocket expenses incurred by them in connection with certain activities on the Company&#8217;s behalf, such as identifying and investigating possible business targets and business combinations.&nbsp;&nbsp;As of the date hereof, the Company has received a total of $1,500,000 in loans from our Sponsor (the &#8220;</font><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;">Sponsor</font><font style="font-family:Times New Roman;"> </font><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;">Loans</font><font style="font-family:Times New Roman;">&#8221;), and the Sponsor Loans remains outstanding as of the date of this proxy statement.&nbsp;&nbsp;However, if the Company fails to obtain the Extension and consummate a business combination, they will not have any claim against the trust account for reimbursement.&nbsp;&nbsp;Accordingly, the Company will most likely not be able to reimburse these expenses, including the Sponsor Loans, if a business combination is not completed.</font></p></td></tr></table></div> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, if the Extension Amendment Proposal is approved and we consummate an initial business combination, our Sponsor, officers and directors may have additional interests as will be described in the proxy statement for the business combination.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431850"></a><a name="US_FEDERAL_INCOME_TAX_CONS"></a>U.S. F<a name="US_FEDERAL_INCOME_TAX_CONS"></a>ederal Income Tax Considerations</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following discussion is a summary of the material U.S. federal income tax considerations for U.S. Holders and Non&#8209;U.S. Holders (each as defined below, and together, &#8220;<font style="font-weight:bold;font-style:italic;">Holders</font>&#8221;) of public shares (i) of the Extension Amendment Proposal and (ii) that elect to have their public shares redeemed for cash if the Extension Amendment Proposal is approved.&nbsp;&nbsp;The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight:bold;font-style:italic;">Code</font>&#8221;), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;<font style="font-weight:bold;font-style:italic;">IRS</font>&#8221;), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect the tax consequences discussed below. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the transactions contemplated by the Extension Amendment (including any redemption of the public shares in connection therewith) with respect to any public shares held through the units (including alternative characterizations of the units).</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This discussion is limited to holders that hold their public shares as a &#8220;capital asset&#8221; within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a holder&#8217;s particular circumstances, including the impact of the alternative minimum tax or the Medicare contribution tax on net investment income. In addition, it does not address consequences relevant to holders subject to special rules, including, without limitation</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">banks;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">certain </font><font style="font-family:Times New Roman;">financial institutions;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">regulated investment companies or real estate investment trusts;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">insurance companies;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">brokers, dealers or traders in securities;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">traders in securities that elect mark to market;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">tax-exempt organizations or governmental organizations;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">U.S. expatriates or former citizens or long&#8209;term residents of the United States;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">persons that hold their public shares as part of a straddle, constructive sale, hedge, wash sale, conversion or other integrated or similar transaction;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">persons that actually or constructively own ten percent or more (by vote or value) of the Company&#8217;s shares (except as specifically provided below);</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="color:#000000;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax</font><font style="color:#000000;">;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="color:#000000;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein);</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="color:#000000;">persons deemed to sell the Company&#8217;s public shares under the constructive sale provisions of the Code</font><font style="color:#000000;">;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="color:#000000;">persons who acquired their public shares pursuant to the exercise of any employee stock option or otherwise as compensation</font><font style="color:#000000;">;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">tax-qualified retirement plans; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">&#8220;qualified foreign pension funds&#8221; as defined in Section 897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension funds.</font></p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;margin-left:11.54%;text-indent:-3.85%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds public shares, the tax treatment of an owner of such an entity or arrangement will depend on the status of the owner, the activities of the entity or arrangement and certain determinations made at the owner level. Accordingly, entities or arrangements treated as partnerships for U.S. federal income tax purposes holding public shares and the owners in such entities or arrangements should consult their tax advisors regarding the U.S. federal income tax consequences to them of the Extension Amendment Proposal and the exercise of their redemption rights with respect to their public shares in connection therewith. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">THIS DISCUSSION IS ONLY A SUMMARY OF CERTAIN U</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.S.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">F</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EDERAL INCOME TAX CONSIDERATIONS ASSOCIATED WITH THE EXTENSION AMENDMENT PROPOSAL AND THE EXERCISE OF REDEMPTION RIGHTS IN CONNECTION THEREWITH</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">E</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ACH HOLDER SHOULD CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH HOLDER OF THE EXTENSION AMENDMENT PROPOSAL AND THE EXERCISE OF REDEMPTION RIGHTS, INCLUDING THE APPLICABILITY AND EFFECTS OF U</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.S.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">F</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EDERAL NON</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8209;INCOME, STATE AND LOCAL AND NON</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.S.</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">T</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AX LAWS.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Tax Treatment of Non&#8209;Redeeming Stockholders</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A public stockholder who does not elect to redeem their public shares (including any public stockholder who votes in favor of the Extension Amendment) will continue to own its public shares, and will not recognize any income, gain or loss for U.S. federal income tax purposes solely as a result of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Tax Treatment of Redeeming Stockholders</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431851"></a><a name="US_HOLDERS"></a>U<a name="US_HOLDERS"></a>.S. Holders</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As used herein, a &#8220;U.S. Holder&#8221; is a beneficial owner of a public share who or that is, for U.S. federal income tax purposes:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">an individual who is a citizen or resident of the United States;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">a corporation (or other entity taxable as a corporation) that is created or organized (or treated as created or organized) in or under the laws of the United States or any state thereof or the District of Columbia;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">an estate whose income is subject to U.S. federal income tax regardless of its source; or</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">a trust if (1) a U.S. court can exercise primary supervision over the administration of such trust and one or more United States persons (within the meaning of Section 7701(a)(30) of the Code) have the authority to control all substantial decisions of the trust or (2)&#160;it has a valid election in place to be treated as a United States person.</font></p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Generally</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. federal income tax consequences to a U.S. Holder of public shares that exercises its redemption rights with respect to its public shares to receive cash in exchange for all or a portion of its public shares will depend on whether the redemption qualifies as a sale of public shares under Section&#160;302 of the Code.&nbsp;&nbsp;If the redemption qualifies as a sale of public shares by a U.S. Holder, the tax consequences to such U.S. Holder are as described below under the section&#160;entitled &#8220;<font style="font-style:italic;">&#8212;Taxation of Redemption Treated as a Sale of Public Shares</font>.&#8221;&nbsp;&nbsp;If the redemption does not qualify as a sale of public shares, a U.S. Holder will be treated as receiving a corporate distribution with the tax consequences to such U.S. Holder as described below under the section&#160;entitled &#8220;&#8212;<font style="font-style:italic;">Taxation of Redemption Treated as a Distribution</font>.&#8221;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whether a redemption of public shares qualifies for sale treatment will depend largely on the total number of shares of the Company&#8217;s stock treated as held by the redeemed U.S. Holder before and after the redemption (including any stock of the Company treated as constructively owned by the U.S. Holder as a result of owning public warrants) relative to all of the stock of the Company outstanding both before and after the redemption.&nbsp;&nbsp;The redemption of public shares generally will be treated as a sale of public shares (rather than as a corporate distribution) if the redemption (1) is &#8220;substantially disproportionate&#8221; with respect to the U.S. Holder, (2) results in a &#8220;complete termination&#8221; of the U.S. Holder&#8217;s interest in the Company or (3) is &#8220;not essentially equivalent to a dividend&#8221; with respect to the U.S. Holder.&nbsp;&nbsp;These tests are explained more fully below.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining whether any of the foregoing tests result in a redemption qualifying for sale treatment, a U.S. Holder takes into account not only shares of the Company&#8217;s stock actually owned by the U.S. Holder, but also shares of the Company&#8217;s stock that are constructively owned by it under certain attribution rules set forth in the Code.&nbsp;&nbsp;A U.S. Holder may constructively own, in addition to stock owned directly, stock owned by certain related </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">individuals and entities in which the U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older has an interest or that have an interest in such U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older, as well as any stock that the holder has a right to acquire by exercise of an option, which would generally include public shares which could be acquired pursuant to the exercise of public warrants.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to meet the substantially disproportionate test, the percentage of the Company&#8217;s outstanding voting stock actually and constructively owned by the U.S. Holder immediately following the redemption of public shares must, among other requirements, be less than eighty percent (80%) of the percentage of the Company&#8217;s outstanding voting stock actually and constructively owned by the U.S. Holder immediately before the redemption (taking into account redemptions by other holders of public shares).&nbsp;&nbsp;There will be a complete termination of a U.S. Holder&#8217;s interest if either (1) all of the public shares actually and constructively owned by the U.S. Holder are redeemed or (2)&#160;all of the public shares actually owned by the U.S. Holder are redeemed and the U.S. Holder is eligible to waive, and effectively waives in accordance with specific rules, the attribution of stock owned by certain family members and the U.S. Holder does not constructively own any other public shares (including any stock constructively owned by the U.S. Holder as a result of owning public warrants).&nbsp;&nbsp;The redemption of public shares will not be essentially equivalent to a dividend if the redemption results in a &#8220;meaningful reduction&#8221; of the U.S. Holder&#8217;s proportionate interest in the Company.&nbsp;&nbsp;Whether the redemption will result in a meaningful reduction in a U.S. Holder&#8217;s proportionate interest in the Company will depend on the particular facts and circumstances.&nbsp;&nbsp;However, the IRS has indicated in a published ruling that even a small reduction in the proportionate interest of a small minority stockholder in a publicly held corporation where such stockholder exercises no control over corporate affairs may constitute such a &#8220;meaningful reduction.&#8221;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If none of the foregoing tests is satisfied, then the redemption of public shares will be treated as a corporate distribution to the redeemed U.S. Holder and the tax effects to such a U.S. Holder will be as described below under the section&#160;entitled &#8220;<font style="font-style:italic;">&#8212;Taxation of Redemption Treated as a Distribution</font>.&#8221;&nbsp;&nbsp;After the application of those rules, any remaining tax basis of the U.S. Holder in the redeemed public shares will be added to the U.S. Holder&#8217;s adjusted tax basis in its remaining shares of the Company&#8217;s stock or, if it has none, to the U.S. Holder&#8217;s adjusted tax basis in its public warrants or possibly in other shares of the Company&#8217;s stock constructively owned by it.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Taxation of Redemption Treated as a Distribution</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the redemption of a U.S. Holder&#8217;s public shares is treated as a corporate distribution, as discussed above under the section&#160;entitled &#8220;<font style="font-style:italic;">&#8212;Generally</font>,&#8221; the amount of cash received in the redemption generally will constitute a dividend for U.S. federal income tax purposes to the extent paid from the Company&#8217;s current or accumulated earnings and profits, as determined under U.S. federal income tax principles.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Distributions in excess of the Company&#8217;s current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. Holder&#8217;s adjusted tax basis in its public shares.&nbsp;&nbsp;Any remaining excess will be treated as gain realized on the sale of public shares and will be treated as described below under the section&#160;entitled &#8220;<font style="font-style:italic;">&#8212;Taxation of Redemption Treated as a Sale of Public Shares</font>.&#8221;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any dividends received by corporate U.S. Holders will be taxable at regular corporate tax rates and will generally be eligible for the dividends received deduction if the requisite holding period is satisfied.&nbsp;&nbsp;With respect to non-corporate U.S. Holders and with certain exceptions, dividends may be &#8220;qualified dividend income,&#8221; which is taxed at the lower applicable long-term capital gain rate provided that the U.S. Holder satisfies certain holding period requirements and the U.S. Holder is not under an obligation to make related payments with respect to positions in substantially similar or related property.&nbsp;&nbsp;It is unclear whether the redemption rights with respect to the Company&#8217;s public shares may prevent a U.S. Holder from satisfying the applicable holding period requirements with respect to the dividends received deduction or the preferential tax rate on qualified dividend income, as the case may be.&nbsp;&nbsp;If the holding period requirements are not satisfied, then non-corporate U.S. Holders may be subject to tax on such dividends at regular ordinary income tax rates instead of the preferential rate that applies to qualified dividend income.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Taxation of Redemption Treated as a Sale of Public Shares</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the redemption of a U.S. Holder&#8217;s public shares is treated as a sale, as discussed above under the section&#160;entitled &#8220;<font style="font-style:italic;">&#8212;Generally</font>,&#8221; a U.S. Holder generally will recognize capital gain or loss in an amount equal to the </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">difference between the amount of cash received in the redemption and the U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s adjusted tax basis in the public shares redeemed</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny such capital gain or loss generally will be long</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;term capital gain or loss if the U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s holding period for the public shares so disposed of exceeds one year</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It is unclear, however, whether the redemption rights with respect to the Company&#8217;s public shares may suspend the running of the applicable holding period for this purpose.&nbsp;&nbsp;If the running of the holding period is suspended, then non-corporate U.S. Holders may not be able to satisfy the one-year holding period requirement for long-term capital gain treatment, in which case any gain on a sale or taxable disposition of the shares or warrants would be subject to short-term capital gain treatment and would be taxed at regular ordinary income tax rates.&nbsp;&nbsp;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">L</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ong</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;term capital gains recognized by non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;corporate U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">olders generally will be eligible to be taxed at reduced rates</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;T</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he deductibility of capital losses is subject to limitations.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Holders who hold different blocks of public shares (including as a result of holding different blocks of public shares purchased or acquired on different dates or at different prices) should consult their tax advisors to determine how the above rules apply to them.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Holders who actually or constructively own at least five percent (5%) by vote or value (or, if the public shares are not then considered to be publicly traded, at least one percent (1%) by vote or value) or more of the total outstanding Company stock may be subject to special reporting requirements with respect to a redemption of public shares, and such holders should consult with their tax advisors with respect to their reporting requirements.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ALL U.S. HOLDERS ARE URGED TO CONSULT THEIR TAX ADVISORS AS TO THE TAX CONSEQUENCES TO THEM OF A REDEMPTION OF ALL OR A PORTION OF THEIR PUBLIC SHARES PURSUANT TO AN EXERCISE OF REDEMPTION RIGHTS.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431852"></a><a name="INFORMATION_REPORTING_BACKUP_WITHHOLDING"></a><a name="INFORMATION_REPORTING_BACKUP_WITHHOLDING"></a>Information Reporting and Backup Withholding</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments of cash to a U.S. Holder as a result of the redemption of public shares may be subject to information reporting to the IRS and possible U.S. backup withholding.&nbsp;&nbsp;Backup withholding will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number and makes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Backup withholding is not an additional tax.&nbsp;&nbsp;Amounts withheld as backup withholding may be credited against a U.S. Holder&#8217;s U.S. federal income tax liability, and the U.S. Holder generally may obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for refund with the IRS and furnishing any required information.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431853"></a><a name="NONUS_HOLDERS"></a>Non-U<a name="NONUS_HOLDERS"></a>.S. Holders</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As used herein, a &#8220;Non&#8209;U.S. Holder&#8221; is a beneficial owner of a public share who or that is, for U.S. federal income tax purposes:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">a non&#8209;resident alien individual;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">a foreign corporation; or</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">a foreign estate or trust.</font></p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Generally</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. federal income tax consequences to a Non&#8209;U.S. Holder of public shares that exercises its redemption rights to receive cash from the trust account in exchange for all or a portion of its public shares will depend on whether the redemption qualifies as a sale of the public shares redeemed, as described above under &#8220;<font style="font-style:italic;">Tax Treatment of Redeeming Stockholders&#8212;U.S. Holders&#8212;Generally</font>.&#8221;&nbsp;&nbsp;If such a redemption qualifies as a sale of public shares, the U.S. federal income tax consequences to the Non&#8209;U.S. Holder will be as described below under &#8220;<font style="font-style:italic;">&#8212;Taxation of Redemption Treated as a Sale of Public Shares</font>.&#8221;&nbsp;&nbsp;If such a redemption does not qualify as a sale of public shares, the Non&#8209;U.S. Holder will be treated as receiving a corporate distribution, the U.S. federal income tax consequences of which are described below under &#8220;<font style="font-style:italic;">&#8212;Taxation of Redemption as a Distribution</font>.&#8221;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because it may not be certain at the time a Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older is redeemed whether such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s redemption will be treated as a sale of shares or a corporate distribution, and because such determination will depend in part on a Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s particular circumstances, the applicable withholding agent may not be able to determine whether (or to what extent) a Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older is treated as receiving a dividend for U.S. federal income tax purposes</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;T</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herefore, the applicable withholding agent may withhold tax at a rate of thirty percent (30%) (or such lower rate as may be specified by an applicable income tax treaty) on the gross amount of any consideration paid to a Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older in redemption of such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s public shares, unless (a) the applicable withholding agent has established special procedures allowing Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">olders to certify that they are exempt from such withholding tax and (b) such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">olders are able to certify that they meet the requirements of such exemption (e.g., because such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">olders are not treated as receiving a dividend under the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">302 tests described above under the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">section&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">entitled </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-style:italic;">Tax Treatment of Redeeming Stockholders&#8212;U</font><font style="font-style:italic;">.S. H</font><font style="font-style:italic;">olders&#8212;Generally</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">owever, there can be no assurance that any applicable withholding agent will establish such special certification procedures</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;I</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">f an applicable withholding agent withholds excess amounts from the amount payable to a Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older, such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older generally may obtain a refund of any such excess amounts by timely filing an appropriate claim for refund with the IR</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S.&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">olders should consult their own tax advisors regarding the application of the foregoing rules in light of their particular facts and circumstances and any applicable procedures or certification requirements.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Taxation of Redemption as a Distribution</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In general, any distributions made to a Non&#8209;U.S. Holder of public shares, to the extent paid out of the Company&#8217;s current or accumulated earnings and profits (as determined under U.S. federal income tax principles), will constitute dividends for U.S. federal income tax purposes and, provided such dividends are not effectively connected with the Non&#8209;U.S. Holder&#8217;s conduct of a trade or business within the United States, the Company will be required to withhold tax from the gross amount of the dividend at a rate of thirty percent (30%) of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying qualification for the lower treaty rate).&nbsp;&nbsp;A Non-U.S. Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty.&nbsp;&nbsp;In addition, if we determine that we are likely to be classified as a &#8220;United States real property holding corporation&#8221; (see &#8220;<font style="font-style:italic;">&#8212;Taxation of Redemption as a Sale of Public Shares</font>&#8221; below), the Company will withhold 15% of any distribution that exceeds the Company&#8217;s current and accumulated earnings and profits, including a distribution in redemption of public shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such dividends are attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above.&nbsp;&nbsp;To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular graduated rates.&nbsp;&nbsp;A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items.&nbsp;&nbsp;Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Taxation of Redemption as a Sale of Public Shares</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A Non&#8209;U.S. Holder generally will not be subject to U.S. federal income or withholding tax in respect of gain recognized on a redemption of public shares that is treated as a sale as described above under &#8220;<font style="font-style:italic;">&#8212;Generally</font>,&#8221; unless:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">the gain is effectively connected with the conduct by the Non&#8209;U.S. Holder of a trade or business within the United States (<font style="color:#000000;">and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such gain is attributable)</font>;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;">the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met</font>; or</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;">the Company is or has been a &#8220;United States real property holding corporation&#8221; for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the Non-U.S. holder held public shares and, in the case where the Company&#8217;s public shares are treated as regularly traded on an established securities market, the Non-U.S. holder has owned, directly or constructively, more than five percent (5%) of the Company&#8217;s public shares at any time within the shorter of the five-year period preceding the disposition or such Non-U.S. Holder&#8217;s holding period for the public shares. There can be no assurance that the Company&#8217;s public shares will be treated as regularly traded on an established securities market for this purpose.</font></p></td></tr></table></div>
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular graduated rates applicable to a U.S. Holder, unless an applicable tax treaty provides otherwise.&nbsp;&nbsp;A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.</p>
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Gain described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty), which may be offset by U.S. source capital losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses.</p>
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">If the third bullet point above applies to a Non-U.S. Holder, gain recognized by such Non-U.S. Holder will be subject to tax at generally applicable U.S. federal income tax rates.&nbsp;&nbsp;In addition, the Company may be required to withhold U.S. federal income tax at a rate of fifteen percent (15%) of the amount realized upon such redemption. The Company will be classified as a &#8220;United States real property holding corporation&#8221; if the fair market value of its &#8220;United States real property interests&#8221; equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus other assets used or held for use in a trade or business, as determined for U.S. federal income tax purposes.&nbsp;&nbsp;It is not expected that the Company would be a United States real property holding corporation in the immediate foreseeable future.&nbsp;&nbsp;However, such determination is factual in nature and subject to change and no assurance can be provided as to whether the Company would be treated as a United States real property holding corporation in any year.</p>
<p style="text-align:left;margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Non-U.S. Holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431854"></a><a name="INFORMATION_REPORTING_BACKUP_W"></a><a name="INFORMATION_REPORTING_BACKUP_W"></a>Information Reporting and Backup Withholding</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information returns will be filed with the IRS in connection with payments of dividends on, and the proceeds from a sale of, public shares.&nbsp;&nbsp;A Non&#8209;U.S. Holder may have to comply with certification procedures to establish that it is not a U.S. person in order to avoid information reporting and backup withholding requirements.&nbsp;&nbsp;The certification procedures required to claim a reduced rate of withholding under a treaty generally will satisfy the certification requirements necessary to avoid the backup withholding as well.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Backup withholding is not an additional tax</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;T</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he amount of any backup withholding from a payment to a Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older generally will be allowed as a credit against such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s U.S. federal income tax liability and may entitle such Non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;U</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.S. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">older to a refund, provided that the required information is timely furnished to the IRS.</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431855"></a><a name="FOREIGN_ACCOUNT_TAX_COMPLIANCE_ACT"></a><a name="FOREIGN_ACCOUNT_TAX_COMPLIANCE_ACT"></a>Foreign Account Tax Compliance Act</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions commonly referred to as &#8220;FATCA&#8221; impose withholding of thirty percent (30%) on payments of dividends (including constructive dividends) on public shares to &#8220;foreign financial institutions&#8221; (which is broadly defined for this purpose and in general includes investment vehicles) and certain other non&#8209;U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied by, or an exemption applies to, the payee (typically certified as to by the delivery of a properly completed IRS Form W&#8209;8BEN&#8209;E).&nbsp;&nbsp;Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules.&nbsp;&nbsp;Under certain circumstances, a Non&#8209;U.S. Holder might be eligible for refunds or credits of such withholding taxes, and a Non&#8209;U.S. Holder might be required to file a U.S. federal income tax return to claim such refunds or credits.&nbsp;&nbsp;While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition public shares on or after January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely.&nbsp;&nbsp;Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non&#8209;U.S. Holders should consult their tax advisors regarding the effects of FATCA on their redemption of public shares.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431856"></a><a name="REQUIRED_VOTE"></a><a name="REQUIRED_VOTE"></a>Required Vote</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The affirmative vote by holders of 65% of the Company&#8217;s outstanding Class A common stock and Class B common stock, voting together as a single class, is required to approve the Extension Amendment.&nbsp;&nbsp;If the Extension Amendment Proposal is not approved, the Extension Amendment will not be implemented and the Company will be required by its charter to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem 100% of the outstanding public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board in accordance with applicable law, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of the Company&#8217;s directors, executive officers and their affiliates are expected to vote any common stock owned by them in favor of the Extension Amendment.&nbsp;&nbsp;On the record date, the initial stockholders beneficially owned and were entitled to vote 8,625,000 founder shares, representing 20% of the Company&#8217;s issued and outstanding common stock.</p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company&#8217;s initial stockholders or advisors, or any of their respective affiliates, may purchase public shares in privately negotiated transactions or in the open market prior to or following the special meeting, although they are under no obligation to do so.&nbsp;&nbsp;Such public shares purchased by the Company or our Sponsor would be (a) purchased at a price no higher than the redemption price for the public shares, which is currently estimated to be $10.01 per share and (b) would not be (i) voted by the initial stockholders or their respective affiliates at the special meeting and (ii) redeemable by the initial stockholders or their respective affiliates.&nbsp;&nbsp;Any such purchases that are completed after the record date for the special meeting may include an agreement with a selling stockholder that such stockholder, for so long as it remains the record holder of the shares in question, will vote in favor of the Extension Amendment Proposal and/or will not exercise its redemption rights with respect to the shares so purchased.&nbsp;&nbsp;The purpose of such share purchases and other transactions would be to increase the likelihood that the proposals to be voted upon at the special meeting is approved by the requisite number of votes and to reduce the number of public shares that are redeemed.&nbsp;&nbsp;In the event that such purchases do </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">occur, the purchasers may seek to purchase shares from stockholders who would otherwise have voted against the Extension Amendment Proposal and elected to redeem their shares for a portion of the trust account</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny such privately negotiated purchases may be effected at purchase prices that are below or in excess of the per</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">share pro rata portion of the trust account</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny public shares held by or subsequently purchased by our affiliates may be voted in favor of the Extension Amendment</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;N</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">one of the initial stockholders, advisors or their respective affiliates may make any such purchases when they are in possession of any material non</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8209;public information not disclosed to the seller or during a restricted period under Regulation M under the Exchange Act.</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431857"></a><a name="RECOMMENDATION"></a><a name="RECOMMENDATION"></a>Recommendation</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As discussed above, after careful consideration of all relevant factors, our Board has determined that the Extension Amendment Proposal is in the best interests of the Company and its stockholders.&nbsp;&nbsp;Our Board has approved and declared advisable adoption of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OUR BOARD RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE EXTENSION AMENDMENT PROPOSAL.&nbsp;&nbsp;OUR BOARD EXPRESSES NO OPINION AS TO WHETHER YOU SHOULD REDEEM YOUR PUBLIC SHARES.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The existence of financial and personal interests of our directors and officers may result in a conflict of interest on the part of one or more of the directors or officers between what he, she or they may believe is in the best interests of the Company and its stockholders and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for the proposals.&nbsp;&nbsp;See the section&#160;entitled &#8220;<font style="font-style:italic;">The Extension Amendment &#8212; Interests of the Company&#8217;s Directors and Officers</font>&#8221; for a further discussion.</p><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="_Toc106431858"></a><a name="ADJOURNMENT_PROPOSAL"></a><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="ADJOURNMENT_PROPOSAL"></a>THE ADJOURNM</font><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">ENT PROPOSAL</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431859"></a><a name="OVERVIEW"></a><a name="OVERVIEW"></a>Overview</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Adjournment Proposal, if adopted, will allow our Board to adjourn the special meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, the Extension Amendment Proposal.&nbsp;&nbsp;The Adjournment Proposal will be presented to our stockholders only in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431860"></a><a name="CONSEQUENCES_IF_ADJOURNMENT_PROPOSAL_IS_"></a><a name="CONSEQUENCES_IF_ADJOURNMENT_PROPOSAL_IS_"></a>Consequences if the Adjournment Proposal is Not Approved</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Adjournment Proposal is not approved by our stockholders, our Board may not be able to adjourn the special meeting to a later date in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431861"></a><a name="REQUIRED_VO"></a><a name="REQUIRED_VO"></a>Required Vote</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The approval of the Adjournment Proposal requires the affirmative vote of a majority of the votes cast by the Company&#8217;s stockholders represented in person (including virtually) or by proxy.&nbsp;&nbsp;Accordingly, if a valid quorum is otherwise established, a stockholder&#8217;s failure to vote by proxy or online at the special meeting will have no effect on the outcome of any vote on the Adjournment Proposal.&nbsp;&nbsp;Abstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the outcome of the Adjournment Proposal.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431862"></a><a name="RECOMMENDAT"></a><a name="RECOMMENDAT"></a>Recommendation</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As discussed above, after careful consideration of all relevant factors, our Board has determined that the Adjournment Proposal is in the best interests of the Company and its stockholders.&nbsp;&nbsp;Our Board has approved and declared advisable the adoption of the Adjournment Proposal.</p>
<p style="margin-top:10pt;text-align:center;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OUR BOARD RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE ADJOURNMENT PROPOSAL.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The existence of financial and personal interests of our directors and officers may result in a conflict of interest on the part of one or more of the directors or officers between what he, she or they may believe is in the best interests of the Company and its stockholders and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for the proposals.&nbsp;&nbsp;See the section&#160;entitled &#8220;<font style="font-style:italic;">The Extension Amendment &#8212; Interests of the Company&#8217;s Directors and Officers</font>&#8221; for a further discussion.</p><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="PRINCIPAL_STOCKHOLDERS"></a><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="PRINCIPAL_STOCKHOLDERS"></a>PRINCIPAL S</font><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">TOCKHOLDERS</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth information regarding the beneficial ownership of our common stock as of June 27,&#160;2022, the record date of the special meeting, by:</p> <div></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">each of our executive officers and directors; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;margin-top:10pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;margin-top:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">all our executive officers and directors as a group.</font></p></td></tr></table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them.&nbsp;&nbsp;The following table does not reflect record or beneficial ownership of the public warrants or private placement warrants as these warrants are not exercisable within 60 days of the date of this proxy statement.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The beneficial ownership of our common stock is based on 43,125,000 shares of common stock issued and outstanding as June 27, 2022, consisting of 34,500,000 shares of Class A common stock and 8,625,000 founder shares.</p> <div></div>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Class A</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.62%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Class B</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.64%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percentage</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name and Address of Beneficial Owner<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Beneficially</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Owned<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percentage</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Class</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Beneficially</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Owned<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percentage</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Class</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Terrence (Terry) M. Pegula</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,615,000</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gary L. Hagerman, Jr.</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John P. Sieminski</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James S. Morrow</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">William A. Fustos</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,000</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thomas W. Corbett, Jr.</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Benjamin Wingard</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jacob Long</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adam Gusky</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,452</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All officers and directors as a group</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; (10 individuals)</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,952</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,625,000</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">East Sponsor, LLC<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup><sup style="font-size:85%;line-height:120%;vertical-align:top"></sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,615,000</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ClearBridge Investments, LLC<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,191,098</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.4</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adage Capital Partners, L.P.<sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,036,387</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Glazer Capital, LLC</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,397,627</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.66%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.6</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="text-align:justify;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:3pt;margin-top:0pt;margin-right:84.62%;text-indent:0%;font-size:8pt;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;">less than 1%.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;"><a name="_9kMHG5YVt4886DIR5qAkQy9CGzn4bG3MFEFHIEK"></a><a name="_9kMHG5YVt4886DIR5qAkQy9CGzn4bG3MFEFHIEK"></a>Unless otherwise noted, the business address of each of the following entities or individuals is c/o East Resources Acquisition Company, 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;"><a name="_9kMH5M6ZWu5997BGQFksBV"></a><a name="_9kMOCM6ZWu5997BDNFksBU"></a><a name="_9kMH5M6ZWu5997BGQFksBV"></a>Interests shown consist solely of founder shares, classified as shares of Class B common stock.  <a name="_9kMOCM6ZWu5997BDNFksBU"></a>Such shares are convertible into shares of Class A common stock on a one-for-one basis, subject to adjustment.  Excludes forward purchase shares that will only be issued, if at all, at the time of our initial business combination.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;"><a name="_9kMH6N6ZWu5997BGQFksBV"></a>East Sponsor, LLC is the record holder of the shares reported herein.  East Asset Management, LLC is the managing member of East Sponsor, LLC, and Terrence M. Pegula and Kim S. Pegula are the managing members of East Asset Management, LLC.  <a name="_9kMH6N6ZWu5997BGQFksBV"></a>As such, they may be deemed to have or share beneficial ownership of the Class B common stock held directly by East Sponsor, LLC.  Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.</p></td></tr></table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">According to a Schedule 13G/A filed with the SEC on February 9, 2022, </font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ClearBridge</font><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Investments, LLC, which is the beneficial owner of 2,191,098 shares of Class A common stock, acts as investment manager of, and exercises investment discretion with respect to, certain private investment funds. The business address of each stockholder is 620 8th Ave., New York, New York 10018.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;">According to a Schedule 13G/A filed with the SEC on February 10, 2022, Adage Capital Partners, L.P., which is the beneficial owner of 2,036,387 shares of Class A common stock, acts as investment manager of, and exercises investment discretion with respect to, certain private investment funds. The business address of each stockholder is 200 Clarendon Street, 52nd floor, Boston, Massachusetts 02116. </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;">According to a Schedule 13G filed with the SEC on February 14, 2022, Glazer Capital, LLC, which is the beneficial owner of 2,397,627 shares of Class A common stock, acts as an investment manager of, and exercises investment discretion with respect to certain private investment funds. The business address of each stockholder is 250 West 55th Street, Suite 30A, New York, New York 10019.</p></td></tr></table></div><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="DELIVERY_DOCUMENTS_TO_STOCKHOLDERS"></a><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="DELIVERY_DOCUMENTS_TO_STOCKHOLDERS"></a>DELIVERY OF DOCUMEN</font><font style="font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">TS TO STOCKHOLDERS</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the rules of the SEC, the Company and its agents that deliver communications to its stockholders are permitted to deliver to two or more stockholders sharing the same address a single copy of the Company&#8217;s proxy statement.&nbsp;&nbsp;Upon written or oral request, the Company will deliver a separate copy of the proxy statement to any stockholder at a shared address who wishes to receive separate copies of such documents in the future.&nbsp;&nbsp;Stockholders receiving multiple copies of such documents may likewise request that the Company deliver single copies of such documents in the future.&nbsp;&nbsp;Stockholders may notify the Company of their requests by emailing or writing the Company at the Company&#8217;s principal executive offices at 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487, info@eastresources.com, Attn: Kelly Seward .</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-align:center;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:10pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><a name="WHERE_YOU_CAN_FIND_MORE_INFORMATION"></a><a name="WHERE_YOU_CAN_FIND_MORE_INFORMATION"></a>WHERE YOU CAN FIND MORE INFORMATION</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company files annual, quarterly and current reports, proxy statements and other information with the SEC.&nbsp;&nbsp;The SEC maintains an internet web site that contains reports, proxy and information statements, and other information regarding issuers, including us, that file electronically with the SEC.&nbsp;&nbsp;The public can obtain any documents that we file electronically with the SEC at http://www.sec.gov.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may obtain additional copies of this proxy statement, at no cost, and you may ask any questions you may have about the Extension Amendment Proposal or the Adjournment Proposal by contacting us at the following address or email:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-align:center;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">East Resources Acquisition Company<br />7777 NW Beacon Square Boulevard</p>
<p style="margin-top:0pt;text-align:center;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Boca Raton, Florida 33487<br />Attn: Kelly Seward<br />Email: info@eastresources.com</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may also obtain these documents at no cost by requesting them in writing or by telephone from the Company&#8217;s proxy solicitation agent at the following address and telephone number:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Morrow Sodali LLC<br />333 Ludlow Street, 5th Floor, South Tower<br />Stamford, CT 06902<br />Tel: (800) 662&#8209;5200 (toll&#8209;free) or<br />(203) 658&#8209;9400 (banks and brokers can call collect)<br />Email: ERES.info@investor.morrowsodali.com </p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to receive timely delivery of the documents in advance of the special meeting, you must make your request for information no later than July 18, 2022 (one week prior to the date of the special meeting).</p> <div></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:10pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc106431866"></a><a name="ANNEX_A"></a><a name="ANNEX_A"></a>ANNEX A</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PROPOSED CERTIFICATE OF AMENDMENT TO THE<br />AMENDED AND RESTATED<br />CERTIFICATE OF INCORPORATION<br />OF<br />EAST RESOURCES ACQUISITION COMPANY</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">East Resources Acquisition Company, a corporation organized and existing under the by virtue of the General Corporation Law of the State of Delaware (the &#8220;<font style="font-weight:bold;font-style:italic;">DGCL</font>&#8221;), does hereby certify:</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:72pt;"></font>The name of the corporation is East Resources Acquisition Company.&nbsp;&nbsp;The corporation was originally incorporated pursuant to the DGCL on May&#160;22, 2020, under the name of East Resources Acquisition Company.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:72pt;"></font>The date of filing of the corporation&#8217;s original Certificate of Incorporation with the Secretary of State of the State of Delaware was May&#160;22, 2020, and the date of filing the corporation&#8217;s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware was July 23, 2020.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:72pt;"></font>The Board of Directors of the corporation has duly adopted resolutions setting forth proposed amendments to the Certificate of Incorporation of the corporation (as amended and restated prior to the date hereof), declaring said amendment to be advisable and in the best interests of the corporation and its stockholders and authorizing the appropriate officers of the corporation to solicit the consent of the stockholders therefor, which resolutions setting forth the proposed amendment are substantially as follows:</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RESOLVED, <font style="font-weight:normal;">that Section&#160;9.1(b) of Article&#160;IX of the Amended and Restated Certificate of Incorporation of the corporation is amended and restated to read in its entirety as follows:</font></p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Immediately after the Offering, a certain amount of the net offering proceeds received by the Corporation in the Offering (including the proceeds of any exercise of the underwriters&#8217; over&#8209;allotment option) and certain other amounts specified in the Corporation&#8217;s registration statement on Form S&#8209;1, initially filed with the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight:bold;font-style:italic;">SEC</font>&#8221;) on July&#160;2, 2020, as amended (the &#8220;<font style="font-weight:bold;font-style:italic;">Registration Statement</font>&#8221;), shall be deposited in a trust account (the &#8220;<font style="font-weight:bold;font-style:italic;">Trust Account</font>&#8221;), established for the benefit of the Public Stockholders (as defined below) pursuant to a trust agreement described in the Registration Statement.&nbsp;&nbsp;Except for the withdrawal of interest to pay taxes, none of the funds held in the Trust Account (including the interest earned on the funds held in the Trust Account) will be released from the Trust Account until the earliest to occur of (i) the completion of the initial Business Combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Corporation is unable to complete its initial Business Combination by August 27, 2022 (the &#8220;<font style="font-weight:bold;font-style:italic;">Deadline Date</font>&#8221;) and (iii) the redemption of shares in connection with a vote seeking to amend such provisions of this Amended and Restated Certificate as described in Section&#160;9.7.&nbsp;&nbsp;In the event that the Corporation has not consummated an initial Business Combination by the Deadline Date, the Board of Directors, in its discretion, if requested by the Sponsor, upon five days prior written notice to the Corporation, may extend the Deadline Date by one month each on up to five occasions, for up to an additional five months, but in no event to a date later than January 27, 2023 (or, if the Office of the Delaware Division of Corporations shall not be open for business (including filing of corporate documents) on such date the next date upon which the Office of the Delaware Division of Corporations shall be open, provided that the Sponsor (or its affiliates or its permitted designees) loans to the Corporation by deposit of funds into the Trust Account $0.033 for each Offering Share that is not redeemed (the &#8220;<font style="font-weight:bold;font-style:italic;">Initial Loan</font>&#8221;), and an additional (ii) $0.033 for each Offering Share that is not redeemed by the last day of that extension period, not later than seven calendar days after the beginning of the next extension period (the &#8220;<font style="font-weight:bold;font-style:italic;">Additional Loans</font>&#8221; and, collectively with the Initial Loan, the &#8220;<font style="font-weight:bold;font-style:italic;">Loans</font>&#8221;) in exchange for a non-interest bearing, unsecured promissory note and (ii) the procedures relating to any such extension, as set forth in the Trust Agreement, shall have been complied with. The gross proceeds from the issuance of such promissory note(s) shall be held in the Trust Account and used to fund the redemption of the Offering Shares in accordance with this <font style="text-decoration:underline;">Article IX</font>. If the Corporation completes its initial Business Combination, it will repay the amounts loaned under the promissory note out of the proceeds of the Trust Account released to it. If the Corporation does not complete a Business Combination by the Deadline Date, the Loans will not be repaid.&nbsp;&nbsp;Holders of shares of Common Stock included as part of the units sold in the Offering (the &#8220;<font style="font-weight:bold;font-style:italic;">Offering Shares</font>&#8221;) (whether such Offering Shares were purchased in the Offering or in the secondary market following the Offering </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A-1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:10pt;margin-top:10pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and whether or not such holders are the Sponsor or officers or directors of the Corporation, or affiliates of any of the foregoing) are referred to herein as &#8220;</font><font style="font-weight:bold;font-style:italic;">Public Stockholders</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font></p> <div></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:72pt;"></font>That thereafter, said amendment was duly adopted in accordance with the provisions of Section&#160;242 of the DGCL by written consent of stockholders holding the requisite number of shares required by statute given in accordance with and pursuant to Section&#160;228 of the DGCL.</p>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF<font style="font-weight:normal;">, the corporation has caused this Certificate of Amendment to be signed this day of [</font><font style="font-weight:normal;">&#9679;</font><font style="font-weight:normal;">], 2022.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:49.95%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Terrence M. Pegula</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer, President and Chairman</p></td>
</tr>
</table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A-2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> &nbsp;&nbsp;&nbsp;&nbsp; <div></div></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gjceruz4dpzk000001.jpg" title="" alt="" style="width:624px;height:817px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EAST RESOURCES ACQUISITION COMPANY &#115; FOLD HERE &#8226; DO NOT SEPARATE &#8226; INSERT IN ENVELOPE PROVIDED &#115; Signature&nbsp;&nbsp;Signature, if held jointly&nbsp;&nbsp;Date 2022. Note: Please sign exactly as name appears hereon. When shares are held by joint owners, both should sign. When signing as attorney, executor, administrator, trustee, guardian, or corporate officer, please give title as such. Please mark your votes like this X CONTROL NUMBER PROXY THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; PROPOSALS 1 AND 2. PLEASE DO NOT RETURN THE PROXY CARD IF YOU ARE VOTING ELECTRONICALLY. INTERNET &#8211; www.cstproxyvote.com Use the Internet to vote your proxy. Have your proxy card available when you access the above website. Follow the prompts to vote your shares. Vote at the Meeting &#8211; If you plan to attend the virtual online special meeting, you will need your 12 digit control number to vote electronically at the special meeting. To attend the special meeting, visit: https://www.cstproxy.com/eastresources/2022 MAIL &#8211; Mark, sign and date your proxy card and return it in the postage-paid envelope provided. Your Internet vote authorizes the named proxies to vote your shares in the same manner as if you marked, signed and returned your proxy card. Votes submitted electronically over the Internet must be received by 11:59 p.m., Eastern Time, on July 24, 2022. . YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY. IMMEDIATE - 24 Hours a Day, 7 Days a Week or by Mail Vote by Internet - QUICK &#72; &#72; &#72; EASY 1. Approval of an amendment (the &#8220;Extension FOR AGAINST ABSTAIN FOR AGAINST ABSTAIN Amendment&#8221;) of the Company&#8217;s Amended and Restated Certificate of Incorporation to extend the date by which East Resources Acquisition Company (the &#8220;Company&#8221;) must consummate a business combination (the &#8220;Extension&#8221;) from July 27, 2022 (the date that is 24 months from the closing date of the Company&#8217;s initial public offering of our units (the &#8220;IPO&#8221;)) to January 27, 2023 (the date that is 30 months from the closing date of the IPO). 2. Approval of a proposal for the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gjceruz4dpzk000002.jpg" title="" alt="" style="width:624px;height:718px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#115; FOLD HERE &#8226; DO NOT SEPARATE &#8226; INSERT IN ENVELOPE PROVIDED &#115; PROXY THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS EAST RESOURCES AC QUISITION COMPANY The undersigned appoints Gary Hagerman and John Sieminski, and each of them as proxies, each with the power to appoint his substitute, and authorizes each of them to represent and to vote, as designated on the reverse hereof, all of the shares of common stock of East Resources Acquisition Company (&#8220;ERES&#8221;) held of record by the undersigned at the close of business on June 27, 2022 at the Special Meeting of Shareholders of the Company to be held on July 25, 2022, or at any adjournment thereof. THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS INDICATED. IF NO CONTRARY INDICATION IS MADE, THE PROXY WILL BE VOTED IN FAVOR OF PROPOSAL 1 AND PROPOSAL 2, AND IN ACCORDANCE WITH THE JUDGMENT OF THE PERSONS NAMED AS PROXY HEREIN ON ANY OTHER MATTERS THAT MAY PROPERLY COME BEFORE THE SPECIAL MEETING. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS. (Continued and to be marked, dated and signed on the other side) Important Notice Regarding the Internet Availability of Proxy Materials for the Special Meeting of Shareholders To view the Proxy Statement and to Attend the Special Meeting, please go to: https://www.cstproxy.com/eastresources/2022 </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:1pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:6pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>gjceruz4dpzk000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gjceruz4dpzk000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .< L$# 2(  A$! Q$!_\0
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MPWE[)::?=@:EK%W8W!\IQBVE:,^;_N_*WS=.:LW?AK49_#D>GQV>HVX/BQI
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'_H7]&_\*JSH_P"%MZC_ -"_HW_A56==/=>/["S?4!/INI(-.>%;QMD9$/F
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MM1I-K<H&B5"7<MN8XZ$X'&2!VKK:;5B4[A1112&%%%% !1110 4444 %%%%
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M8JESW'T(SGT[VBD]K#3L[_UT_P D<5X4T+7-)TS0U>Y9))7EN=861$8RNZ\
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M3EEX'0GG'<U1W>'K[5H_#3Z1;RBVM$O(4DM4,*(6*C:#T/'H*;=WIY_^W/\
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M*=/&@+1N' .J6V,@Y_NUM_&#4;B_T?3/#>CJ+F[UF4%%1QAXUPW7.,$XYSC
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MK:2WO)[J\%I,D=PNZW)5FRRC)_AZ'%;UQ<0VMO)<7,T<,,:EGDD8*J@=22>
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M<  =R20*Y?7?%\O]D3&Q6XL-1MKZUAN(+A(V=%DD7T+*0RD\@G\#22NN7O\
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M8MMQO0A]PSSALC(Y& > <X/%"NM/ZTO_ )@]=?ZZ?Y(Z.BBBD 4444 %%%%
M!1110 5D>)]'G\0>'+S2;>^^Q-=)Y;3^5YF%)^88R.HR.O>M>BDU=68T[.Z,
M[0M(AT'0K+2H#NCM85C#8QN(ZG'N<G\:P_#?@G_A&O$>M:C;ZCYEEJ;^8;(P
MX$;YSD-NYZMV'4>E=;15-W=R;:6/,]0^$;+?SS^&_$^HZ##<,7FMH"QC)/IM
M=<#V.:Z;P=X(TWP;9SQVKRW%S<MNN+F<Y>0_T')_.NFHI+16&]=SS35_A#%-
M?W-UX>\07VA"[)-Q!!EHWSUP RX'L211X3^%MSX+\1V]_IFKQ3VTD9CO$N+<
M;R.N8R.F3CC^=>ET4+W=@>NYP7BCX91:WKC:YI.M7FB:I(H66:VR0XQCH&4@
MX '7MTJQX.^'<'A?49]6N]4NM6U:=-CW5QV7V!).>!R2>G:NUHH6FP/7<Y;2
M/!W]E>-]9\1_;_-_M)%7[/Y.WR\8_BW'/3T%<]JOPE+ZQ<ZCX=\2W^@M=L7G
MCM]Q5B>>-KJ0,Y.#GKQBO2J*+;+L'?S.1\*> +#PI87T<-S/=7M\I%Q=S\LQ
MP>WIDD]<^]6O _A/_A#/#HTG[;]LQ,TOF^5Y?WL<8R?3UKI**=^HK'+Q>#O*
M^(D_BS[?GS;46_V7R>G3G?N]NF*3QKX._P"$PM].B^W_ &3['="XSY/F;\#I
M]X8^M=3126EO+_AQO6_G_P ,<YXN\%Z7XRL8X+_S(IH&W07,)Q)&>^/4'TKD
M(?@Y+=SQ#Q%XNU36+.%@R6TA95^F6=N.W&*]2HH6@7T.3\:^"(_%N@6>DPW:
MZ?%:SI*A6#>,*I4*!N&.OZ4_QQX)M?&NAQV$T_V:>%P\-R(]Y0]",9&01VSZ
M>E=310]59^HT[6\C+\.:/_PC_AVPTGS_ #_LD0C\W9MW8[XR<?G5+Q;X-TWQ
MA8Q07IEAG@;?;W,!Q)$WL?3@<>U=#10]7=B6FQYA:?!]Y[Z"7Q)XJU+7+>!@
MT=M-N"Y'8[G;CZ8KLO%'A/2_%NC_ -G:C$0BG=%)'P\3=,K_ (=*W:*'JK M
M'<\K'P;N+EEM]6\9ZM?Z6AREFQ8  '@9+L.GHH_"NH\5>!K;Q!X0@\.V=PNG
M6T#QM&5B\P*%SQC</7KFNLHH!:.YQ6K?#NWU7QOI/B1[W9]@1%:W\G/FE"2I
MW;N.2.QZ5>T;P@-(\8ZWX@%[YO\ :@7]QY.WR\?[63G/T%=/10M/Q_'<+?I^
M&QS/@[PC_P (E%J2?;OM7VV\:ZSY6S9G^'[QS]>*?XV\+R^,-#72EU(V,+3*
M\Q$/F&15YV_>&.<'//2NCHH[>7Z!?J0QVL,5DMHL8$"QB()CC:!C'Y5PFG?#
M)]/\'ZUX:76R]IJ$F^$FVYM^1D??^;H/2O0:*'K>_4%I:W0YB3P7:W7@"/PI
M>3>='';+"+@1X(91\K@9."#SC-'@3PA_PA6@-I?V[[9NG:;S?)\OJ ,8W'T]
M:Z>BG=W;[BMHEV.6N?!OVCXBVGBS[?M^SVQM_LODYW?>YW[N/O=,=JZFBBET
ML/K<**** "BBB@ HHHH *XO2_AW:V.H:Y-<7TEU:ZG')#';E-OV:.1F9U5LG
M.2V>@Z5TFNWTNE^']1OX%1I;:VDF0."5)521G';BN('C+Q&3&A&E*\VB?VLI
M^SR$)C&4(\SYLYX/&/0TM-?Z[_HF4D^G];?YF[;^#6:2T.IZ@+M+&UDM+,1P
M>441U"EG.X[FVC&0%'7BLZ3X<)+8:1'+<V-Q<Z9;M:QO=:<)HGB.,;HR_P!\
M8^\#Z\=JDMO&M[=ZKI\*6]ND%WH1U,A@2RR<87.<;>?3/O6/)\0]=30](U.2
MQAAMKJR^T378LYIH!)N(V'8VZ(8&=Q#_ $XJGOK_ %O_ ,$E=E_6W^:-K5_A
M[#J>G6UAY]B;>&W\C$^F1DH3U>(QE/+8Y]UZ?+7765JMC86]HCNZP1+&'<Y9
M@!C)/K7(Z5J^IZA\19H1?P/I?]E0W,<,<9(^<GD-D9.1U(Z<8')-/4WU&'XF
MZE/ILEJDT6A(_P#I,;.IQ*QQA64\XZYX]#2;MOUO^%P6NW2WXV_S-"S\!I!X
MH@UN6ZMFE@>1U>"R6":7>",2NK;7 SV13P,GUKVGP]DLY=+C35U-EIE_)>01
M&U^<[]V59]_."W! 'T-4I?B->78LDTVP832Z8NH,GV.:Z+EB0(E\K[F2#\[9
M XXK=\3^)KS2/ $GB"VM%CNQ%%(+>[1OD+LH*L 0<C)]*=K?+3\?\T"]YV[_
M .7^3*>F^ IK2#2K2ZU=;FRTVY>[BC6UV.9"6(RV\_*-QXQG/?'%2:7X$_LV
M/PXO]I>9_8KSMGR,>=YH/^U\N,^^?:J^K^+=6TS5+;2%2&:]DM'O&EATZ>92
MN["QA(V+ GNY.!Z<XJ:#Q/K6L:A'8:=9V]A=II\=[/'J,;D[G)'E8!4KC!RV
M#C^[1_7Y_P"3_JP-]7_5_P#AR32_ W]FPZ%&=1\W^RKBXFSY&WS?-W<?>^7&
M[KSG':H[/P))8VFCP1:G&3I-Y)/;,UL3F-]V4<;^3\Q^88[?+534?'6IP:WJ
M%E9Z:\YTTPK-;PV4\[3EP"VV1!MC"@\;@=V.U1C7I='U37[V&SMDM8M7@COG
M(D+F-XD&_EL J67H , \9YH6O]>:_P P;_K[R_HGP\LM$U..>$V+6\,DDD0_
MLZ/[1\^?E:<Y) R<;0IZ DTEMX#FM6TB!-77^S])O6NK: VOSX.[Y&??SC=P
M0!QU!ZU1F\?WICLVAAC":I>SQ64RVDMQM@B'WVCC.YRQ!P%Q@'/:K<?B[5[P
MZ%8I8+8:CJ4DX=KVWD"HD75A&2K'<,$ D8SWQ0KZ6_KK^ 2ZW\_U.B\2:#;>
M)="N-*NF*QR[2& !VLI!!P>O(Z5@KX C&E36OGV%O+-<P3LUEID=O&!$X8*%
M4[CG!Y9CC/ '2H_AYO\ ^$8U7S-OF?VG>;MO3.\YQ[5C>!]9U+2?#GA*UD%I
M)9:D)((PJ-YD3C>P8MNPP.,$8!'J:2[KR_S_ $!]GY_@;O\ PKVS3Q#/J49L
M?*GNQ=R+-IT<LX?C*I*V=JDC.-N0<X(K0TWPU=Z1=NECJWE:6]T]TUM]F#2%
MG.63S"2 F3G 7=_M5EZ)XQU+5M5TG2S;VR7>+@ZJ K?N?*;8-@SQN8@C.>*A
M^*-E-)HT%Y]NG6"&ZMU%JA 1V,R_,W=L#H.G?K371='I^GZ ^MRU9^ FM+G2
MV&IJT&FW\UY#']GPQ$F<HS;^Q8\X'T[U9U#P<UU-JJ6^H""QU<@W\)@WNQVA
M3Y;[ALR!SD-[8K,\264T7Q$\+7DE]/*DMW(L=N2!'"!"<X ZDG)R?I6OXETG
M7==T76M+BFL(8KI4CM7^?<$./,\SMGKC'XTNG]>0_M:_UJRE>^ $NK/Q%:Q:
MAY,>L>0%'D;O($2J /O?-G;[5/=^!X;V36&FO7']H26\T92/!@>$ *<Y^;D9
M[>GO7-)I\]R+O0;32-.9=(U&"2^M["!;>/4(6CR 59MNX<9#,0<=172^ )KA
MM)U&"6(Q1VNI7$,$98-Y<8;(3(XPN2..!C I[_UZ$[)?UW_R':EX6U+6+.);
M_6XI;F"[CNH0+("W4IQM,>_<P.<G+]<8QTJMI_@(V,MM(=3$AAU:34SBV"[B
MZ%2G#<<G.?PQWJC9>-=8-I::E>16!LIM7;33##&XD WE%<,6(ZCE<>^1TK;\
M0:WJ=EXDT/2-/%HO]HB??+<1L^S8@8$!6&>O(_44D]+K^MG_ )#:Z/\ K=?Y
MG,^(O",T/AG2_#]C)=3WYOG=+N&V95BBE9O-W-RJC8Y&"<G P*]'M;:*SM(;
M6!0D,*+&BCLH& *X3P_XVU;4+GP^;V&R$&K-<0E(8W#1O#GYMQ8C!Q]W''J:
M] I[('OK_6IR=YX*%R=3MH[\1:7JL_GWML8-SLWRY"2;AM!VC.58]<$5-+X,
MM9/&EOXA$S*(8@IM0ORM(H*K)G/4*S#&/3TK!\46/]H?$[3(?[)T[4\:7*WD
M:@^V,?O%^;/EOS^'<\UIZAJ%SX=L-,TS3;'2K"]N3*PL[:)YT 4%CL51$#VR
M6* 9[U*=HI_UU7Z#:NVOZ[C=.^'EGINL?:X6L?(%P]RH;3HVN S9.TS-D[03
MD8 /3YJV/"?A_P#X1?P[;Z3]J^T^2SMYOE[,[F+=,GUQUKCY/B'K3^'M'U:/
M3%M[>[MY)+BY-I+<QQR*Q 4A&#(IQG=\V/0U)<>+M1A\3M?B\@FTB+P^=2^R
MPQL0YS_"Y(.<CABO XV@Y-5MI_6E_P#(-7_7R_4ZS5/#[7^OZ;J\-TL,MG'+
M$R/$7$B2 9 ^8;3QP>?I63I_@-;&#PW"VH>:NB^<#^XQYXD4C^]\N,^]9D?C
MO6?[$U*^?3]PBTPWT$[:?<00J_\ SR8O]_J#N4@$9X%6U\1^(FO_  [9!]+\
MS6+66X+_ &:3$.V-648\SYN2<\C/MW+6T_KK_P $5^O]=/\ -%CP[\/[3P[J
M$,T+6+0VV_R=NG1K.=W_ #TF.6; ) V[>.N:U_%'A_\ X2724L?M7V;;<13[
M_+WYV,&QC(ZXZU%X3UA_$_A2WOKV")9)O,CFC490E6*' .>#CH?6N9\-Z!HL
M7Q!\5>7I%@HM#:M;!;9!Y),9)*<?+D^F*'=/7IK]P6T?]>1J3>!/-L]0M_[2
MQ]LU==3W>1]S#*=GWN?N]??I1JG@&'5)M9\V[3[/J4L-SY;0;C'-&  <EL,A
M Y4CN>:Y[P[XEU./3='TW2K;3;2&32[B\P\<L@1DD( &9,D'W/?KVJ[:?$+4
M([:UO=0M;9[>ZT>74DBMU8/&8\94L6(8'/H,>_6EHOE^G_[/X#U;_K^NI?/P
M]C:VM$%S96\D.I17[?8M-2"-A'G"!5.>_5F8]>W%7]2\(?VC?:[<_;O+_M73
MULMODY\K&[YL[OF^]TXZ=:K^%/%&I:U>K%>64GD2VBW*7*V$]O&C$C,1,G#D
M @AE(!YX%;'B?6_^$>\/W.I"'SGCVJD>< LS!1D]ADC-.2>S_KH)/M_74YNX
M^&EI+=I<)-9,[VT-O.UUIT=PW[L;0\>\D(2.#D,.G'%;^G^'CIOB74=4@N4\
MB_BB62W,7*M&-JE6!P!CMM_'M7.:]XSUCPY;ZK;7"6-SJ%K91WL,L<+I$RM)
ML*LI<G([$-SZ#%;6BZYJ%SXGU+1M06U8V]O#<Q26Z,GROGY2"QR1CJ,9]!1=
MO4+67]>7_ .EHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 0WEI!?V4]G<IYD$\;1R)DC<I&",CGI6.NA>
M'6OOLJQQ&[AT_P"Q^2+AMZVIXP5W9P<?>Z\=:U;^^MM,T^>^O)#';6Z&25PI
M;:HZG !)_"N U6_G@\3^*-7TV3YH?#L<L,RJ& ;,C*<$8[9P12;7]>C&K]/Z
MU1U5UX8\/I:6S7$ A@T^V,*2?:7CV0XY5F##<N!R&)%1Q>#O#DEC:I;VI%O'
M;B&-K>[E7S(3R%9E;,B<DX8D<UQFI^(]3O;9;&:\#P7/A*2\G0(@W2E<;L@9
M'4\#CVIUUXEUG0].MM-MYP9=2TVT&CDQJ=DIVI(.GS8#*_S9[]JJSNUU_P""
MU^C%T3_K[/\ G^!WTVG:-IMTFL2B*S:VM_(\XS&*-8AT5AD*0.V1QVJK-H/A
MWQ),=77;=-/!]G^TVMXZAX@<[<QL 1G.?7H:?XDU'3=#\-MJ&M1I=1VNQU#Q
M!F>4?=VC& Q;H1TKD+3^W=.\(7=U=6UU!?Z_?F5X[6WDG-A&X +%44G(5?3[
MQ'O2[^7Z_P!/^F"Z>?\ 7X:'6OH/AS7;:!XXH9H(8S;(UI<,B[ <&,F-AN7(
MP5.1QTI_B"'P[_8?]G:[+9VVFR[8Q'-.(%.T@A0<CI@< ]JYKX5WUA;>#+:S
M\[R3]LGBA2X!C,AWL0%W ;CCKC.,'/2M'QSK4&CPVR6NG1WWB"^#VNGQ^6"P
MW8WG=U"C@GUX^H)76PX[^AHZ[9>&[G[')K$\$);,-O(;PP-(&ZH&5E+ \?+D
M@^E0:II?A,SV=C?O9VTQB%O;P+=FW:2/_GGM5E+I_LG(]JX>\TJ;1$N-,OY1
M+]F\(21Q.QR"X;]YC/\ P#\,58UBXEU'2M+\)V%DK^(-4L+=M1NF3#6\*@?,
M[=2V<X!_J,NW;O\ JU^EQ;+^O)_J=A>:5X1EUF&UNC9)?LB!;,77E^:J?<W0
MA@'"XXRIQCBM)_#^ER1:G$]H&34SF\4NW[WY0OKQP .,5QGB)UUCQ+!X3T.U
M03)/!>:O?JNTQA"I7+#[TA '7M^GH,5U;SRS10SQ220-LE1'!,;8SA@.AP0>
M:6Z_K^M_R#9F?-X;TF?3+/3VM2EO9A?LWE2O&\.!@;74A@<<9SSWIK^%]&>P
MM;(6?EPVCF2 PRO&\;'.2'4ALG)R<\Y.<UKT47 H:7HNGZ-926>GV_DV\DC2
M,F]FRS'+'))-4M,\(:'H\EO)8V3(;566!7GD=8MWWBJLQ )SR0,UN44 <UX<
M\.3:=K>M:W>I;)>ZG*A,=NY=8T5< ;BJDDG)/ K9U/2K+6+/[)?P^=!O63;N
M*_,I#*<@@\$"KE%';R#N4[O2K*^O+*[N8=\]D[26[[B-C$;2< X/![YJM<>&
MM'NS?FXLED.H%&N27;YB@PI'/RD8X*X]:U:* ,5O">BM8FT:T9D,PN#(T\AF
M\T<!_-W;]P'&=V<<5I65C;:=:+:VD(BA4DA1DY).223R22223R:L44 <AX9\
M$6^E1>;J,<<UXE[-<Q%)I#&N]B5;8<+O .,XR.QK7@\+Z-:W5M<PV>V:VEFE
MB;S7.UY?]8<$X.??IVQ6Q10!C6OA71;+^S_L]EL_L]Y)+7]ZY\MI,[SR><Y/
M7/M4<'A/3+/4-.NK2+R5L//,2!F;F4Y;DD\9R?RQ@<'=HH!ZF3J/AO3-5U"*
M_N4N5NXHS$DUO=S0,$)R1F-ER,TR;PMI-Q%:QSQW,IM69H99+V9I5W<,/,+[
MBI'!4DCVK9HH Y]?!7A]+6"WALG@C@1HT\BYEB;8Q+%"RL"5)).TDCVJV?#F
MD&XMIQ9JCVUN;6,([*OE$8V,H.&7V8'%:M% &%%X.T&*UNK9;)FBNH?L\@>>
M1SY7_/-26)1?]E2 *N#0M-6ZT^Y%M^^T^)H;5M[?NT8 $=>> .N:T:* *>EZ
M59:+8)8Z?#Y-LC,RIN+8+$L>22>I-);Z38VNH7M_#!MN;W9]H?>QW[1A>"<#
M ],5=HH QK3PGHEB8#;V6PP6[VL?[USMB<[F7D\Y/?K2V_A;1;7[)Y5BH%I;
M-:0AG9@L38W*03SG ZY-;%%']?U][ YR7P3HITN^LH+<Q_:[?[,SR2R2E(^R
MKN;*J.H4$#VK:ET^UGTTZ?<0I-:F,1-'(,AEQCFK-% &(WA'1'T^ZL9;1Y8;
MM56<S7$CNZJ<JN]F+8!Z#.!5Z'2;&WU2;4HH-MY-$D,DF]CE%SM&,XXR>U7:
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT9K)TN8&6R)B3RT24$_=8IT!. ?UKL:Y1O'VFQ6LMQ<V5_;A;$ZA$LJ)NGA
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2[)ULB_1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *X8ZSJMOXG_TN_=M.EOC:Q?9T@EM^
M1@1M@B5)0>I^9?8=NYJE_8^F?VD=1_LZS^W$8-SY"^:1_O8S^M*VH=#@/#-_
M?:)HGAV2;52;&[MY_,BE@0I J(SAEV@.<8YR3GMBHKSQ5K-BUZD.J74X?1)K
MZ*2ZMH(]LB[=IC51N"_-T?/0<GFO2%TZQ1($2RMU2W!$*B)0(\C!V\<9!(XJ
MK%X;T*!&2'1=.C1E965+5 "&QN!P.AP,^N*KK_7F.^IQ]_JGB*VU3^S(;S4+
M@PV"WC7$4=FI=V+ AO,*#RUV_P /S<\MZMG\1ZXDL.HW%X(;%(K9YTL#;W*0
MEP"XF!.\AL_*T;=,'![]S>Z1IFIK$M_IUI=K$<QB>!7V'U&1Q23Z-I=S>17E
MQIMG+=0C$4\D"LZ8_NL1D?A0GJ3T+M%10VT%NTK001Q-,_F2%$"[VP!N..IP
M!R?2I:0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+?#7G^1_PD.D^=NV>7]MCW;LXQC/7/:CK8+Z7-FBBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#+O/#6@ZC<&XOM$TVZG/!DGM(W8_B1FJ_\
MPAGA7_H6M&_\ (O_ (FMRB@##_X0SPK_ -"UHW_@!%_\31_PAGA7_H6M&_\
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M5OF&Y;8S*)"/4+G.*;_;&F?;9++^T;/[7$A>2#SU\Q%'4E<Y ]ZX>3PKJO\
M:]W"ZZC+;W.IK?++#-:I"H!!!8LAF#+MQA<@C R 3A=,\*ZK;:G;6]RNH/#;
MZC)>B=9;58/F9FS]PS%B&P5.!U^;&*E:I#>ESH]*\8:9K%I'?07=E'9E)G=I
MKI5D01L 3MY&W!R3N&,KZUJ0:QIEU'<26^HV<T=N<3M'.K"(_P"T0>/QKSIO
M"FNOHALO[.821:9J-H"9H\2/+(K1X^;H1GKC&.<<5H^)= N/M,MRB6\%HEG9
MQ_O94C25HY]WE')XR, 9XR0*>FGG_P $?]?E_G^!VUCJNG:HK-I]_:W:J 6-
MO,L@&<XS@GT/Y5.T\*31PO+&LL@)1"P#-CK@=\9%<1H^K"V\3>)+Z?3)K<O)
M90F!6C:3>V5!;:Q7/S D!B<8^E;/C(30:/'JMHBO>:=,L\*,V-^?D9,^ZL0/
M?%)]Q(T[C7-(M(A+<ZI90QF4PAY+A%!<<%<D_>'IUJ=K^S0S![N!3#&)I09
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M80%22%VH,D*IPTFX\=>>9+G3-,TB[EF;6[VSAPU]-912J%DV8WO@+YF.F0K
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M KIM/LH=-TZVL;<8AMXUC0>P&*N33;9$4TDOZ_K_ "+-%%%24%%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5Y_=_#_6+VVU:"3Q!8A=3NH[J8KICY5TVX"_O^!\HZY[UZ!11
MUN!Y]=?#[6;IK\_\)'91"\NH[PK'I1Q%.F,.F9CR=HR#D>U9NG^ /$US/J@U
M#6+:&UFU,W36[V7F1WF-I5R%E!09'W<CISD8KU.BA:;?UM_D@>O]?UW."F\#
M:]<ZK#>W/B:TN$@N/M,-M-IC.D<G8AC/Y@ SPN[;[4Y_!'B&43&;Q5!,\D-Q
M"))+"1FC69@6VGS^,8 'H!7=T4#OK<X>]\$ZO?:GI-_+K&EA]+5DAC72I-C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=U]#:O.D8A>15P#M,A48121C+$9[&E/B_2;6* 7UR8YFCB:8QP2/'"7 P'<
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M(SM#G82SLW&>>]4TM;$ZZ&Q1114C"BBB@ HHHH **** "BBB@ HHHH ****
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MR!T7<[$X&3@9QR:IVN0KV-&BBBI&%%%% !1110 4444 %%%% !1110 4444
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MI]I,5#>7<721M@]\,0<4ZZUW2+&VAN;S5;&WMY_]5+-<(BR=_E).#^% %/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K#\9_P#(B^(?^P9<_P#HIJW*P_&?
M_(B^(?\ L&7/_HIJ -6]_P"/"X_ZY-_*O&/ O@O5=8T3P_>O;>'K6PAF6Y6[
MM[=OM\FQR=K-C'.,=>F*]M90RE6 *D8((ZU%:VEM8VR6UI;Q6]O&,)%$@15'
ML!P*%H[^GX ]58X7P]KVCZ3XH\71:EJUC9R/J*LJ7-RD98>4O(#$<5Q^MNDG
MQ+\0R1MX,=&2V96\1'((,8P8OZ_A7K5UX6\/7MS)<W>@Z7<7$AR\LMG&[,?<
MD9-%SX6\/7DWG76@Z7/*0%WRV<;-@# &2.P %)=/)6'??S_SN<!XNU6W.A>&
M=#AL4U""Y9;B[MM A\Z)X8B"RQJ#]PO@?0&JVD:A9WGPQ\0Z#JDU_I$5@[1
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MV7@V\VS;VCT2)9(!\ORE@0?G^]SZ5S7AO1;)O@AJ%W;:=;#4)K.[0SQP#S7
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MI5Q;?$73;?6;'0](N;>W>>T_LBT,27H9=K N3R5Z[<5CVH\(GX<ZO]J_LO\
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M;V*[LTNV9D=<70&)@-P!.>&_"N*T;2D?2=,=?#XL+V^NFBM/$3ZDZJL@D/\
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M ]Q_V$[_ /\ 2N:MRL/PG_R![C_L)W__ *5S4 ;E%%% !1110 4444 %%%%
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M_P"PM1_Z&S6?^_5G_P#&*/["U'_H;-9_[]6?_P 8K<HH P_["U'_ *&S6?\
MOU9__&*/["U'_H;-9_[]6?\ \8K<HH P_P"PM1_Z&S6?^_5G_P#&*/["U'_H
M;-9_[]6?_P 8K<HH P_["U'_ *&S6?\ OU9__&*/["U'_H;-9_[]6?\ \8K<
MHH P_P"PM1_Z&S6?^_5G_P#&*/["U'_H;-9_[]6?_P 8K<HH P_["U'_ *&S
M6?\ OU9__&*/["U'_H;-9_[]6?\ \8K<HH P_P"PM1_Z&S6?^_5G_P#&*/["
MU'_H;-9_[]6?_P 8K<HH P_["U'_ *&S6?\ OU9__&*/["U'_H;-9_[]6?\
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M&F:;+++8Z=:6LDQS*\$"H7/JQ Y_&G=?U\P9@>!;G4;_ $JYO-1U6XO'%U/
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M;HTT9=%\V9(R2H92<!R<9'2H/LOBK_H,Z-_X*9?_ ))H\6?\@>W_ .PG8?\
MI7#6K>V=OJ%E/9W<2RV\Z&.1&'#*1@T,:,K[+XJ_Z#.C?^"F7_Y)H^R^*O\
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M+MA&V8BGWLC&3T[ Y[51U;XA^%M#>V34M4\AKF!;B$?9Y6W1MT/RJ<=.AYH
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MWTD+/ LIMT;YE4HW'W3C';/M7MM%):6_K8J^_P _Q/+?#T:?9_&%OXC6]O\
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M9?[&NQ!'#$Q8 2*549WC'J>#7J%%']?A87]?C<\<TSQ#I&C> [CPAJMC<GQ
M8YHGL#:.[74C%L.&Q@@\'<3VJ>71]=_X2CPGIMKK']EZG!H166X-NMQT*@KM
M8X_'VKURBCK=_P!:-?J'2R_K5/\ 0\PU[PK+X>\.:;(6N-7C@UE=1U0K"-TV
M<[F$8XP#@[:GCUS3?&?CC0;WPXDMQ%IPF:[O! T:JA3 BRP&220<?C7I%%"_
MK[K _P"OS/!8M3ATW5X+#09I[L_VAO/AK5=+W26[E^9%D&0N <@YX')S6MXH
M&L^*_$VO#2_#IU6TMK8Z7%,+V.$039#LX#?>(;:./[O7FO9**.B_KR'?5O\
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MTFQL=<-G!QF@#3HIJ.DD:R1LKHPRK*<@CU%.H ***9-*EO!)-*VV.-2S'&<
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M0#CGYCFM63QK!%+';2:1JBW\LB(EF4B\PAE=E;/F;<$1L/O<$<XJ/_A/M/\
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M,^7,NUUYP0>WX@D'J"15JC9CO?\ KN%<QX@EO]7N-1\-VFGVTT+V*//+-?-
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M_$YI7=PLM5V/1Z*Q_#%]=:CH45Q=MYCF214FV;?.178(^.VY0#QQSQ6Q0U8
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MVW]H6[F>)DV,A/!+,",9(Y^E4?#&OW^H:K:1S:E]JEG@D>_LO*1?[/<$;5X
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M&4A@0R@Y![4 6Z*P_P#A$]._Y^=9_P#!U>?_ !VC_A$]._Y^=9_\'5Y_\=H
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M9+>*622ZQ(K3$  (%(.&.#\PXY&>E9]GXL\1!+>XFM+6<?8KJYFA6XV+B.4
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MXI(O,VD3R'/F-N;(+8;)YYS@],4RY\*Z-=L6EM7#EY'9H[B2-FWX+@E6!*G
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MGVN*]_M&2,)&1->B9<R<[@$ERP/W2=K,G/RXYKLJ;5B4%%%%(84444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% ''>'_#&@:A8W=U>Z'IES<2:G?[YIK2-W;%U*!DD9/  _"M7_A#/"O\
MT+6C?^ $7_Q-'A/_ ) ]Q_V$[_\ ]*YJW* ,/_A#/"O_ $+6C?\ @!%_\31_
MPAGA7_H6M&_\ (O_ (FMRB@##_X0SPK_ -"UHW_@!%_\31_PAGA7_H6M&_\
M "+_ .)K<HH P_\ A#/"O_0M:-_X 1?_ !-'_"&>%?\ H6M&_P# "+_XFMRB
M@##_ .$,\*_]"UHW_@!%_P#$T?\ "&>%?^A:T;_P B_^)K<HH P_^$,\*_\
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M (FMRB@##_X0SPK_ -"UHW_@!%_\31_PAGA7_H6M&_\  "+_ .)K<HH P_\
MA#/"O_0M:-_X 1?_ !-'_"&>%?\ H6M&_P# "+_XFMRB@#DK[P_HNE:_X:GT
M[2+"SF;4)$:2WMDC8K]DN#C*@'&0./:NMK#UW_D,>&/^PF__ *27%;E !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!A^$_\ D#W'_83O_P#TKFK<K#\)_P#('N/^
MPG?_ /I7-6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!AZ[_P ACPQ_V$W_ /22XK<K#UW_
M )#'AC_L)O\ ^DEQ6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8\WA+PW<SR3
MS^'M)EFE8O)))91LSL3DDDC))/>H_P#A#/"O_0M:-_X 1?\ Q-;E% &'_P (
M9X5_Z%K1O_ "+_XFC_A#/"O_ $+6C?\ @!%_\36Y10!A_P#"&>%?^A:T;_P
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M ( 1?_$UN44 8?\ PAGA7_H6M&_\ (O_ (FC_A#/"O\ T+6C?^ $7_Q-;E%
M&'_PAGA7_H6M&_\  "+_ .)H_P"$,\*_]"UHW_@!%_\ $UN44 8?_"&>%?\
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MEM8Q+)=3)$CR+&I8]68X4#W)-3UY#'X(U>2*=IM"4P-)8W'V)OLX#/&Y\X*
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MW6EI)C3K^.(/)&<3/.7BQSP<8(/;V--Z?UY7_P" $=?P/1[O7=,L3.+B[13
M\22@ L4:0X0$ 'J36C7F$GA'5MU\_P#9*O=78TZ0W*O%G,3)YJL=V<_*6[@X
MZYXJWH36UKXBU"YN+^T30=&DE2UN7G41B2=@SJ6/ *'*=?XL46Z?UT%?2YZ)
M16'_ ,)GX5_Z&71O_ ^+_P"*H_X3/PK_ -#+HW_@?%_\52&;E%8?_"9^%?\
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M ,50!N45A_\ "9^%?^AET;_P/B_^*H_X3/PK_P!#+HW_ ('Q?_%4 ;E%8?\
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M)G:1B_S@  C=G&,# & *MTNP=SSFY\?:I%97$JQ6&8[PVZR$!4* ,1(3))&
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M#TK;HH R4\,Z1' T/V5G5X9(7,DSNSI(07W,Q)8G:.2<\=:;#X6T>!-JVTC
MERWF7$CE]ZA&W%F.[(4=<],]>:V** *$>CV2:7)II6::UD4JZW%Q)*Q!ZC<[
M%OUX[5"GAS2TM?L_V=VC*2(Q>9W9A)C?N8DLQ.!R3GBM6B@#+G\.Z5<31S2V
MI+QR&0$2N 22&.X X89 .TY&0.*6#0-.MS^[CFVB83*C7,C(CC.-JEB%')X
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M( GE[3]HDR-C,Z@'=G +-QZ''3BM6B@#-M=!T^RN89[:.:)HHUB54N) A4#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
/!1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gjceruz4dpzk000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gjceruz4dpzk000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +1 G(# 2(  A$! Q$!_\0
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MY::[;VL6CWMP(MUFCO(J9/EYQ@  =<$DFIM:^)EU!X2\,S_:H--NM80M/>M
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M=#N!XB\0:I=7L%S);WT]NY:RC$CR9&9!)]Y0>?D''--*[\K?\ 'HCU^BBBD
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M]DV;CYF_<3G&,8_&L*Q^'>I_\(_KGAG4+RQ;1[N5Y[2:%7\])"P8%P<+@8'
MZ^M>D5!<7EM:&(7$Z1&:011AC@NQZ >IJ;?UZN_YCOU_K0Y70-*\;P7MJFLZ
MUIW]G6B;!'90$R76!@&0N/E/0_+4_@[PS>^'KWQ!-=RV[KJ.H/=0B)B2JG.
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MU=94BMYBI@1^ F0>G'3\ZZKQ+)JO@_0;'3[+6[^YO]:U*. WMXXD:#>/FV#
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MX4&J^+]$UXWGE_V6)!Y'E9\S>,?>R,8^AK"M_A;;6VF^*+2/4,'79-P?R/\
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M)M(N8W%Q)K]L<Q2 9#*XZ*<8P?6NM^(VF0:SX+N].FU.UT]IF012W4H2-G#
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MVLZ)=SZP+5=,-U%'JURL]PC<#=N7[HY/%;B?"U8_!VFZ*FLR1WFFW1N[6_2
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M(0O<- D*A > $7@=!SGM74TWT$MPHHHI#"BBB@ HHHH **** "BBB@ HHHH
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M'I(N#G\,=374V5E;Z=8P65I$L5O @CCC7HJCH*F.D;>A4M97)Z*** "BBB@
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M4?S2B[]JY&[\CBG;6W9_U85]+]SIZ***0PHHHH **** "BBB@ HHHH ****
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MFN@!<2+$H:; P-YQ\W'K41T/2&TU=-.EV1L$.Y;4VZ>4#G.0N,=>>E$=+?\
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M;@&+1[ZW7[0&+\;4(W;LD\G'KCFO3M,?^U/BAJEZX*QZ7I\5J 2,*\A\QOQ
M"BNF70M(343J*Z58B^)R;D6Z>9G_ 'L9JS'96D+3M%:PHUPVZ8K& 93C&6]3
MCCFG?[_Z0/7^O.YXWJGB6Q^(WBA].N];LM+\*Z?*#()[E(GOG![9/W>/PZ]2
M,;UY=V.A?&.UU.]NH+;3+O1?*M[AW"Q$JP. Q..F/S%=C_PAGA7_ *%K1O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3^-:L<:11K'&BI&@"JJC 4#H *=10!GWN@Z/J5TEU?:38W5P@ 26>V1W4 Y
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M\$$%YI-A<PVXVPQS6R.L8X&%!' X'3TJ"3PIX<F$0ET#2I/*0)'NLXSL4$G
MXX&2>/>M>B@"D-(TP:C_ &B-.M!?8Q]I\A?,QZ;L9J:*RM+>W>WAM88X7+%X
MTC 5BQRQ('!R2<^M3T4 9UAX?T72IVGT[2+"SF9=IDM[9(V(],J!QP*LQV-G
M#;26T5K D$A8O$L8"L6Y;(Z'.3GUS5BB@"HNF:>CV[I8VRO;QF*!A"H,2'@J
MO' P!P*2RTG3=,\W[!I]I:>:<R>1"L>\^IP.:N44 4TTG38[>"W33[18;=_,
MAC$*A8FY^91C /)Y'J:@MO#FA67G?9-%TZ#SD,<OE6J+YBGJ&P.1[&M.B@#'
M3PEX;CBDB3P_I2QR@"1%LHP'P<C(QS@\U>M--L=/M/LEE96UM;<_N88E1.>O
MR@8JU10!C1>$/#,,J2Q>'=)CD1@RNEE&"I'0@[>#6S110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!POCCQ;JV@ZWI.G:;/HEL+R.5WG
MU=W2-=F,#<I&,Y]#68_Q%U9? .I:NL>E/?V-\MIYT3.]I+EE&]3D'&&]>U=)
MKWA)=>\7:-J-W!97.GV<,R307*;]S.!M(4@@XQW(H\6^%!K'A$Z'I4-G:IYL
M3+&5V1!5<,1A0>P/:A;:_P!:_P"0/?\ KM_F8WAKQKK%YXHM](U&X\.:BES#
M)(LVAW#R>1LQ_K-Q. <X%2KXF\7:U+=WOAO3=)?2;6=X1]LE<3710X8IM^5>
M<@;JT+'PE)H/BX:AH26=OI5U%LO;+&P*X^Z\0"X![$<"LY?#'B_1)+RQ\.:G
MI2Z3=S/,/ML3F:U+G+!-O#<DD;J'TMV_&X+^O0MW?C*Z/A/3?%.GVB2::Q#Z
MA RDRQQ]&*$'&5(.<@Y [5)H^N^(M?\ #FHZO9VMG"LA9M(BGC?=(@Z-)\P^
M]VQC'O45UX*N#X<TCPO:W2+HT1']H.S$33J#NVJ , ,W7D<>M:7A;0KWPX+S
M3O.BET=9=^GC>QEA4\F,Y&-H/0Y/%-VUM\OZ_+Y^0=OZ_KS^7F96B^.+CQ-J
MFF6>DVT:[8C+J_G*Q-J1E?*'(^<L#U[#.*[>N>\-Z#<Z/JFOW,[PLFHWOVB(
M1DDA=H&&R!SD=LUT-%]%_7]6V#J%%%%( HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** .&\:6>S7?#S17NI0_;M16
M"X2#49XT9/+8X"JX"\@<@ TV?4+W2?B3'I]I!J>H6B:,&%M'=*V&\TC>QFD7
M)QQG)-=3JFB6VK76FW%P\JOI]R+F(1D ,VTC#9!XP3TQ2?V';?\ "2G7M\WV
MHVGV39D;-F[=G&,YS[_A0M/Q_+_,'U]%^?\ D>;Z'K6JW%_X5\V^O1]HU;4$
MFCDG)W*N[:C8)!"]AR!VJ/0O%5S9^-X]*\5-K-CJKW3K%*MPS6ERK'"+Y;95
M5Z ,@SZGK7<6W@73+6?3YDGO"UA=3W4677EIL[@<+T&>,8/N:E7PA;-<VKWF
MHZC?P6DWGVUO=R)(L;CHV[;YC8SQN8_H*(Z-7"6J=OZU?^9F?$&[>VE\.H;B
M_BMY]2$=PMB\JR2)L8[?W7SGD#@5SFKW6JV6B73_ &G6(-)?6;6.S,KSK=&$
MX$B\_O<$YP#SZ=J]&U31+;5KK3;BX>57T^Y%S$(R &;:1AL@\8)Z8HUK1+;7
M;:W@NGE18+F.Y4Q$ ED.0#D'CUH6GW_AI_D#_3_/_,X>WUV6R?Q%J6ASWMUH
MUAI[%DOY9G=+Q<G;B8^8!MQD<"KNH_:_#OA_3-=BU*^NKQYK870EN&DCN%D9
M58",G:GWLC8!T'6ND_X1FP&NWFJJ95:^@$%W;@CR9P. S+C.['&<]*@@\(VD
M36J2WM]<V=FZO:V<[JT<++]TY"AFQVWLV/P%-/;Y?F[_ '@^OS_)6_KYG'>(
M+[4;/QZGAB#7)8[/6I8YVD,[>;9@9W1HW\/F;?EY&.<5I>*;O7/#NM!=,EFN
M8M<1;.V2:8L+2Y P'&3PI7)('=?>MFX\#:5=6FJPW$EU)+J4XN);DR#S8V7&
MS80/E"XXX/XUHW^@V^I2Z7+<SW!DTV<7$3 J-[A2OS<>YZ8I+9)_TO\ @?\
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MC[Y&"#VQU'6E]I+^MF/HV:NF:S\6)=5M(]2\,:3#8M,HN)(Y5+)'GYB/WQY
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M^S=)E62.:-F,LX0$(&0J F,\D,V<=LUL1^*]&EM9;D73HD,Z6\JRV\D;I(Y
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M=)GMO%6K:H[QF"\AMXXU!.X%-^<\8_B&.:L:AKNFZ7IL>H7=T%M)618Y$5I
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M-#<:??I#/$C[<$ LJLK8Y#'L/E-:[:?J=SX'6TUBT&J7Q ,D/GB%FP^5PZ@
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M<\2O%(K;@<LP4J>AP2>G!J]<:-JUU/XJGDLD234=+BAA5)E8&4)(&4$X. 6
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M#S@GFN\HHOK?^NO^8=+?UT_R.&U.)K/6O$AO-)N[Y=4MHX[0PVS3*X"%3$Q
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M#H*]-JCJ>KV6CQPO>22+YTGE1)%"\KNV"<!4!)X!/3M2CI;^NW^0/6_]=_\
M,X.XT+4)?#&N+#:7$<SZ^]TZI$/,FA$JDE0X(;@9&00<8YHN](>]@N]0MDUW
M4";BS>Y6_M4@^T1Q2;BJ1B.-F('7*\\ $UZ4#D9]:*%I;RM^%O\ ('K?SO\
MCJ>;:[:76K6?BR_T_3;Q+>[L(8(T>V>.2XE5F)81L W *C)'./05WT%];R7L
ME@K-]I@B221#&P 5L@$$C!^Z>A[5;IBQ1K*\JQH)' #.%Y8#ID]\9-/R!_U^
M'^1YEXI&J7MMJ]FFFW<<GV^.2."STPE9HU9#YK38(9B!T4AA@#'!JU%IM_\
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MCC+LY683'CE6 ^4ENV,5W,$Z7$*RH) K=!)&R-^*L 1^524FKJWE8=^OG?\
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M X &XY-)?U^/^8W_ %^'^1YA;.]WIWALZS?:;%I9TZ01R:O;F> S"0C!_>(
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M'K8%H>41V%E>7NADVD<^F?V_*NG^=&&7[/Y#'"9_Y9[U)';@8Z"NR^(6W_A
M=9W;MOV<YV]<9'2N@-S +I;4SQBX9#((MXWE0<%L=<9(&?>@W, NEM3/&+AD
M,@BWC>5!P6QUQD@9]Z3U5OZ_K0/M7_K>_P"IY9KD5I>V^N_\(R//LVT<_;/L
MY+*TX==N[UEVA]W\73/:K6I7^FZ[KVJ26NJE+-M!1&O;9&E"'SCG[O)QGY@#
MP"<XKTZBC_@_C?\ S#I_7E_D>3)-:?V-J-K8VVF>2EWI[F[TB1OLLK&=00$R
M51QCG:3G(R:6TL;6VTRWU:&!$U$^)VB^T@?O-C7+*4SUVD$\=.<UZQ44]Q!:
MQ^9<31PQ[@NZ1@HR3@#)[DD#\::>J?\ 73_(.EOZV?\ F>6:? 9M8+7VLZ?9
MZZNJ,606#O?,@E^50XER82F!G9M //(S5G33I]CXOB%O)8ZI=S7TP>2,20ZA
M;AMQ/FKG,D:\ ;@!C:0#Q7I]107,%R)#;SQRB-S&_EN&VL.JG'0CTI+:W]=
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M\>R.WN-,2=83V>+E2C8X[C@<5L:5IT.CZ3::;;EC#:Q+$A8Y) &,GWIWO?\
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M"PM;N)#E$N(5D53Z@$<5)]BM?.6;[-#YJQF)7\L;@AZJ#Z<#CIQ0_P#/]?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$<=V)Q5;5/!C:CX!M?#":EY+V\<"+=^1NR8R#G9N[[?6C;3T_P"".]_Q_P"
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MBK YV;NIQZUT2+LC5<YV@#-'<71#+E97M)D@D,<S(0C@ [6QP>>.M>2S^/\
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MNG^<)[:=,A@R *%7!!P1WQBJ%OX"F32=<\-R7$7]@7AWV6TDS6S$Y*XQ@J"
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M8X6M(KDS6P'7.[Y 6+''!_2KE9/3N_T_-_@2MM>R_K[OQ-_Q?XX3PI=Z1$;
MW<-^[!Y5EV^2B[<MC:=W#9[=*0^.5/Q!'A:/3RZB(LUYYN '";RH7;SP5YSW
MKG)O"?B#6M.\-VFK68#V=I>6EU)YJ$#='LB?J<YP#[=\4OACPEX@M-6T+4]4
MM1]K_P!,DU!Q(AV,ZJD8X//RH.F<=Z5M_G^M@>R+^B^._%&O6\%Y8^!M]A+(
M4%Q_:T0P VTG:5!XP>*GN_'.N#7]5T[2O"+ZE!ICJL\Z:@D;?,H;A&7).,\
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M1=36\C>9NWK& 2W08SZ<_6L_0_&]_K^@7]U9^'G_ +6M63&FO=JI=' 96WD
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M^<8SCK78W2-):3(@RS1L /?%3*ZB^_\ E_F-6<EV_K\CS[2_B7JEW!IE_?\
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M&'3R^UK^2Q'V=.=N2X8\9XK:UWQKI^AWD=DMIJ.IWLD?F_9M-MS,ZQGHQY
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M9"<;,<YZ>U8=I#J&O>"?%IL97UD374$XU!+5K=K]5V^8@C/]T+C '-"U3?\
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M['.,]Z],JC=Z5!>ZC8WLS.6LF=XD!&W<R[=QXSD D#GN?:KU.^G]>7^0NO\
M7=_YA1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
